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ABSTRACT 
The physiological consequences of major thermal in-
jury center around profound, life-threatening shock oc-
curring in conjunction with the burn and consisting of 
two pathological syndromes: hypovolemic and cellular 
shock. Intravascular hypovolemia following major thermal 
injury results from increased capillary permeability with 
subsequent loss of intravascular fluid into the inter-
stitium. Investigations of burn shock have demonstrated 
the release of circulating factors which effect this 
change in capillary permeability. The purpose of this 
study was to evaluate the effect of a therapeutic regime 
involving the removal of the circulating factors by per-
forming plasma exchange. Fourteen adult patients with 
burns of 40% total body surface area (TBSA) served as 
subjects. Seven were randomly assigned to the control 
group which received standard burn shock resuscitation. 
Seven were randomly assigned to the treatment group which 
received the same resuscitation in combination with plas-
ma exchange. The study period was the first 48 hours 
postburn with the plasma exchange procedures performed as 
soon as was clinically feasible. A total of 937 measure-
ments of physiological variables were made on each pa-
tient. These included vital signs, cardiopulmonary para-
meters, respiratory status, and serum content analysis 
measured upon admission and every 4 hours thereafter 
during the study period. Hourly fluid intake and output 
records were compiled. Descriptive data included age, 
sex, percent TBSA burn and resuscitation requirements. 
Data were analyzed for statistical significance. The 
findings were as follows: the sample was unevenly dis-
tributed, with the treatment group more critically ill 
than the control on the basis of the variable of percent 
TBSA full-thickness injury (p < .01) and the incidence of 
documented inhalation injury. No significant difference 
was found between the groups on the variable of fluid re-
quirement, either in subjects with or without associated 
inhalation injury. Plasma exchange significantly de-
creased platelet count (p < .05) in the treatment group 
when compared with the control but did not alter other 
serum chemistry values. The coagulopathy reported to oc-
cur in burn patients was not observed in this group of 14 
subjects. The plasma exchange group was in significantly 
(p<.05) more normal base excess balance at both postburn 
hour 16 and 24 than the control. There was no evidence 
that plasma exchange performed during burn shock for the 
purpose of removing circulating factors was harmful in 
v 
any way to the treatment subjects. It is recommended 
that the study as designed be continued until the sample 
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CHAPTER I 
INTRODUCTION AND STATEMENT 
OF THE PROBLEM 
The physiological consequences of major thermal in-
jury center around the profound, life-threatening hypo-
volemic shock which occurs in conjunction with cellular 
and immunological disruption within a few minutes of the 
injury. In contrast, the effects of minor and moderate 
burn injuries are limited to the skin. Individuals with 
minor and moderate burn injuries will experience discom-
fort until healing or skin grafting is accomplished, but 
these burns are not life-threatening. With a major burn 
injury, a systemic pathophysiology ensues which requires 
therapeutic intervention to sustain life. The American 
Burn Association (1) has defined a major burn injury as 
one that involves greater than 25% of the total body sur-
face area (TBSA) because this is the extent of injury 
which produces a systemic insult. Major burns are not a 
skin problem; instead, systemic trauma resulting in cel-
lular pathophysiology of all body systems produces the 
condition defined as burn shock. 
The problem of burn shock was recognized only fairly 
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recently and the cause remains unknown. Currently, burn 
shock is treated with large volumes of intravenous re-
suscitation fluid. Since the 1940s, various fluid resus-
citation formulas have succeeded in maintaining patients 
through the initial hypovolemic state of burn shock. In 
the past, treatment has been supportive rather than 
therapeutic. The sequence of events is as follows: 
Within minutes of a major burn injury, the normally semi-
permeable capillary system becomes an open system. 
Intravascular fluid leaks into the interstitial space, 
which results in hypovolemic shock. This process con-
tinues for about 24 hours postburn at which time the sys-
tem regains its capillary integrity. Burn shock resusci-
tation involves the infusion of intravenous fluid at a 
rate faster than the rate of the leak of circulating 
volume fluid for the 24 hour postburn shock period. When 
fluid resuscitation does not occur, the rapidly progres-
sive hypovolemia leads to death. Survival of a major 
burn injury requires prompt fluid resuscitation to sup-
port the patient through the burn shock phase. However, 
at this time, burn shock resuscitation is a supportive, 
rather than a therapeutic, intervention. 
pathophysiology of Burn Shock 
Burn shock consists of two pathological syndromes: 
Hypovolemic shock and cellular shock. The major as-
sumption of this study is that both are nonadaptive com-
pensatory mechanisms; therefore, altering either or both 
syndromes back toward homeostasis will be beneficial to 
the burn patient. 
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The syndrome of intravascular hypovolemia and de-
creased cardiac output following major burn injury results 
from increased capillary permeability with subsequent loss 
of intravascular fluid into the interstitium. The et-
iology of this increase in capillary permeability has not 
been defined. Loebl (2), in 1968, demonstrated that 
cross-perfusion from burned dogs to unburned animals led 
to a decreased cardiac output in the unburned animals, 
suggesting there are circulating factors in the burn se-
rum responsible for burn shock. Investigations of burn 
shock have documented the release of mediators of the in-
flammatory response which can lead to loss of capillary 
seal following major thermal injuries. These substances 
include vasoactive amines (histamines, serotonin), 
products of platelet activation (thromboxanes), products 
of complement activation (C3a, C5a), prostaglandins, 
kinins and endotoxins. Moreover, increased metabolic 
hormones (catecholamines, glucocorticoids) are also asso-
ciated with edema formation (3). More than one circulat-
ing etiological factor appears to be involved in the 
pathophysiology of hypovolemic shock following thermal 
injury. 
The second aspect of burn shock is cellular shock. 
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Increasing data are being accumulated on the mechanisms oc-
curring in the early postburn period at the cellular le-
vel. There appears to be depressed function of the 
sodium-potassium membrane pump and altered adenosine tri-
phosphate (ATP) dynamics. Alteration of the levels of 
ionized magnesium and calcium in the cellular milieu sug-
gests depressed energy utilization; magnesium and calcium 
fluxes occurring in the cell may be important in the 
generation of altered cellular permeability. Experiments 
by Baxter (4) using intracellular electrical potential 
measurements demonstrate membrane potential to be greatly 
decreased following thermal injury with failure to return 
to normal even after successful fluid resuscitation. The 
immunological alterations demonstrated by many inves-
tigators are another aspect of cellular shock associated 
with major thermal injury. The immune response is de-
pressed and the release of histamine and serotonin in-
creased. Burn toxins and circulating myocardial depres-
sant factors have also been described. 
Physiological Consequences of 
Fluid Resuscitation 
The immediate consequence of successful fluid resus-
citation is restoration of the circulating cardiovascular 
volume to a level compatible with life. Without fluid re-
suscitation, most patients with major thermal injury die 
of hypovolemic shock. There are a variety of resuscita-
tion formulae which are successful in restoring circu-
lating volume but none are specifically administered for 
the purpose of restoring cellular function. Present 
therapy is limited to cardiovascular support rather than 
alteration of the burn shock syndrome. 
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Fluid resuscitation for burn shock focuses on in-
fusing intravenous fluid at a rate which produces a mini-
mum of 30-50 milliliters (mL) per hour of urine output. 
Various fluid resuscitation formulas are used to predict 
the amount of fluid which might be necessary to achieve 
the output criteria. The most widely used fluid resusci-
tation formula is the Parkland Formula (5) whereby 
Ringer's lactate is infused at a rate of 4 mL per kilogram 
(kg) of body weight per percent total body surface area 
(TBSA) burn during the first 24 hours postburn. Approxi-
mately one-half of this total fluid volume is given during 
the first eight hours postburn and one-fourth during each 
of the second and third eight hour periods. 
Resuscitation formulas are used as guidelines only; 
the hourly volume of resuscitation fluid administered is 
determined by the clinical parameter of urine output. 
Baxter and Shires (5) report 70 to 80% of all burn 
patients require 4 mL/kg/% TBSA burn of resuscitation 
fluid during the first 24 hours postburn. Moreover, 95% 
of all burn patients required between 3.5 and 4.5 mL/kg/% 
TBSA burn. The problem is that even though 95% of all 
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thermally injured patients can be successfully resusci-
tated using the Parkland formula, the burn shock remains 
so severe for 24 hours postburn that the volume of fluid 
required merely supports the patient's circulatory system 
but does not alter the shock syndrome itself. Patients 
with major burns greater than 60% TBSA may require 20 to 
30 liters of intravenous fluid during the first 24 hours 
postburn. This progresses to massive iatrogenic edema 
which leads to mechanical airway obstruction necessita-
ting tracheal intubation, increased severity of the 
interstitial pulmonary edema associated with inhalation 
injury, prolonged ileus with bowel wall edema, compro-
mised circulation to the extremities necessitating escha-
rotorny or fasciotomy, and to a rapid depletion of serum 
protein with resultant lowered albumin levels. In addi-
tion, edema has been demonstrated to impair wound healing 
secondary to decreased oxygen tension at the cellular 
level. 
The internal environment in which various cellular 
components of the body must exist is drastically altered 
from normal following thermal injury. Even though ther-
mally injured patients demonstrate altered cellular 
function, these abnormalities can be returned to normal 
when the cell is removed from the burn environment. It is 
clinically not possible to remove these cells for the pur-
pose of restoring them to normal; thus, therapeutic inter-
7 
vention has to be aimed at restoring the burn environment 
toward normal. This information indirectly supports the 
use of any treatment modality which could "mimic" removal 
of the cell from the toxic environment. 
With the development of in vivo blood cell separa-
tors, the separation and removal of specific blood compo-
nents for therapeutic purposes is now a practical possibil-
ity in the clinical setting. Although the procedure is 
commonly referred to as plasmapheresis (to take away plas-
ma (6)), plasma exchange is the preferred term for the 
procedure as used in burn patients since the volume of re-
moved plasma is replaced with an equal volume of fresh 
frozen banked plasma. The removal of plasma followed by 
the return of the cellular components of blood was first 
described by Orosez (7) in 1913 for the purpose of cor-
recting uremia in bilaterally nephrectomized dogs. 
During the Twentieth Century, whole blood exchange revo-
lutionized the management of hemolytic diseases of the 
newborn. Ten years have elapsed since the introduction 
of in vivo blood cell separators into clinical medicine. 
These machines were initially developed for the collec-
tion of granulocytes and platelets from normal donors; 
however, their availability in general hospitals has led 
to their therapeutic use in a wide range of medical con-
ditions. Plasmapheresis has a definitive role in the 
management of many immunoproliferative and autoimmune 
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disorders for the purpose of restoring a physiologic 
internal environment. Plasma exchange to reverse or 
alter burn shock has the same goal. 
In summary, fluid resuscitation as it is currently 
accomplished is successful in 95% of all burn patients. 
However, its aim is to support the patient through burn 
shock which requires massive volumes of intravenous fluid 
and leads to iatrogenic complications. Plasma exchange 
seeks to restore the internal environment toward normal 
by removal of hypothesized circulating toxic factors and 
replacing them with banked fresh frozen plasma, which may 
alter the burn shock syndrome in a manner to restore the 
capillary seal. If plasma exchange accomplishes this 
aim, the burn shock and, thus, the massive volume of 
fluid required for resuscitation, will be altered. 
Nursing Treatment of Burn Shock: 
State of the Art 
Burn shock is not addressed specifically as a nursing 
problem in the literature. Burn nursing has traditionally 
occurred within a multidisciplinary setting with all mem-
bers addressing all problems. Pruitt (8) states that the 
vast increase in burn care knowledge confirms the ef-
fectiveness of multidisciplinary care and research. A re-
flection of the overall philosophy of burn care is the 
idea that the people responsible for patient care are the 
ones in a position to identify clinical problems deserving 
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of study and resolution. Pruitt states an indigenous 
nursing staff is of primary importance in the list of 
factors essential for burn care and research because its 
members not only provide the intensive care necessary for 
optimum survival but assist in the identification of 
clinical problems. 
The first burn center staffed by a multidisciplinary 
team in the united States opened at Brooke Army Medical 
Center at Fort Sam Houston, Texas, in 1947. By 1979, 
there were 172 burn facilities with 1,511 beds (9). The 
American Burn~ssociation was established in 1967 with 
membership open to any professional with one year's ex-
perience in burn care. Marvin (9) reports that although 
the physician is regarded as the "captain of the ship," 
the nurse on the burn team traditionally holds the role 
of coordinator of all activities directed toward the care 
of burned patients. Thus there is no nursing research 
per se in burn care but rather a series of articles 
authored by members of the burn team which prominently 
includes nurses. This multidisciplinary approach to burn 
care and its practice in a physically designated area has 
resulted in a higher patient survival rate and a hospital 
time about one-half that of nonunit care (10). 
~rchambeault-Jones and Feller (11) state patients with 
major burns require meticulous and comprehensive care for 
survival and the key member in structuring an environment 
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for recovery is the nurse. The concept that clinical 
nurses are responsible for structuring an environment is 
consistent with the current concept of nursing diagnosis. 
Yet the intensive care setting is where the nursing-
medical diagnosis confusion abounds. Dracup (12) reports 
critical care nurses constantly deal with patients in 
physiological crises but physiological nursing diagnoses 
remain the most problematic. She gives as examples the 
diagnoses of "alterations in cardiac output" and 
lIimpaired gas exchange." 
Guzetta and Dossey (13) have described nursing diag-
nosis in terms of its framework, process, and problems. 
They have identified the problems with using nursing diag-
nosis in critical care as multifaceted and complex. One 
problem which tends to overshadow all others is that of 
territory or, as these authors refer to it, the dependent 
vs. interdependent and independent role of the critical 
care nurse. They state that the dependent and independent 
roles theoretically can be defined yet the lines that se-
parate these roles in practice become fuzzy. Burn nurses 
have the distinct advantage in that their role has been 
accepted as one of interdependence since 1947 by all mem-
bers of the multidisciplinary team, including the nurse. 
Thus activities in a burn unit are burn nursing with burn 
shock resuscitation an integral part of that nursing. 
Shock as a physiologic consequence of thermal injury 
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was recognized only fairly recently. Prior to the early 
1900s, burns were considered a skin problem and therapy 
was focused on wound care. Then in 1897, Tommasoli 
started to treat patients with severe burns by saline in-
fusion (14). Warden (15) correlates the dawn of modern 
burn care with three discoveries. The first was the dis-
covery of anesthesia by Morton, the second was the eluci-
dation of the nature and treatment of burn wound infec-
tion by Lister, and the third was the use of sodium 
chloride in the resuscitation of burn shock by Parascan-
dolo in 1901. Fluid resuscitation is now universally 
recognized as the primary intervention in the emergent 
(first 48 hours postburn) phase. Wooldridge-King (16) 
lists the goals of fluid resuscitation as a) correction 
of antecedent fluid, electrolyte, and protein deficits; 
b) replacement of continuing losses and maintenance of 
fluids without overloading; and c) prevention of exces-
sive edema formation. She also states that basic fluid 
therapy is ordered by the physician but the amount 
infused each hour is based on nursing judgment within 
established protocols. O'Malley and Snow (17) report 
burn unit nurses participate fully in moment-to-moment 
evaluation and treatment by initiating fluid changes and 
beginning ventilatory support when these measures are 
necessary. Christopher (18) describes a model for hemo-
dynamic balance to describe burn shock. 
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Nurses working in burn intensive care areas perform 
nursing assessments which in effect determine the rate of 
intravenous fluid infusion for patients in burn shock. 
These decisions are based upon both knowledge and expec-
tations: specifically, several formulas exist which 
predict these fluid requirements. The most commonly used 
formula is the Parkland formula which predicts that a 
patient with major thermal injury will require 4 mL of 
intravenous fluid for each percent TBSA burn per kg of 
body weight during the 24 hour postburn period. 
The trained burn nurse assumes complete responsi-
bility for determinig the rate of administration. This 
is appropriate since Gordon and Sweeney (19) list among 
areas of nursing diagnoses the states of altered skin in-
tegrity, fluid volume, and cardiac output. Nurses in 
burn intensive care units stabilize the patient's urine 
output by titrating the rate of intravenous fluid admini-
stration. 
Nursing is a practice discipline which occurs in a 
variety of settings. One such setting is an intensive 
care unit: specifically, a burn unit. Here patients are 
critically ill as a result of a catastrophic injury which 
has allowed no time for adaptation, either physiological-
ly or psychologically. The goal of intervention is to 
support the patient through a series of physiologic 
changes as the body attempts to establish compensatory 
13 
adaptations. Burn shock is not a physiologic change to 
which the body can adapt; an external source of adapta-
tion is required for survival. The nursing intervention 
is to provide cardiovascular support via the administra-
tion of intravenous fluids at a rate to assure survival 
until the cessation of burn shock, which is usually self-
limited in a 24-hour time-frame. Fluid resuscitation is 
currently routinely performed by highly skilled burn 
nurses. However the method of plasma exchange, a recent 
advance in therapy for burn shock, has necessitated a 
reevaluation of the methods previously used to resusci-
tate burn patients. 
Plasma exchange is a procedure which involves 
removing the patient's plasma and replacing it with 
banked fresh frozen plasma. The nursing implications of 
this procedure when performed on a patient in burn shock 
are not known, yet the nurse remains responsible for the 
administration of appropriate fluid volumes to assure 
cardiovascular stability while at the same time assessing 
the effect of the procedure. The effects of plasma ex-
change on the patient's fluid requirements and cardiovas-
cular status are unknown. Therefore, nursing research is 
essential to document the patient's response to plasma 
exchange. At this point, plasma exchange is an experi-
mental procedure when used for the purpose of therapeu-
tically altering burn shock. 
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A desired outcome of plasma exchange is to stop the 
loss of capillary seal and, in fact, restore capillary 
integrity. If this occurs, the amount of intravenous 
fluid required to support the cardiovascular system would 
decrease proportionately. The purpose of plasma exchange 
during burn shock is to reverse the loss of capillary 
seal; if this does not occur, there is no reason to 
continue to perform the procedure. 
A review of the literature for the purpose of identi-
fying a nursing model based on a higher theoretical 
framework than nursing diagnosis revealed that none of 
the nursing models were appropriate because none had been 
applied in the intensive care setting. The nursing mo-
dels reviewed are strangely silent on the topic of deva-
stating traumatic injury or disease during the initial 
post trauma period. Rogers includes a cardiac patient in 
an example of the use of her continuum model, but the 
time-frame involves teaching the patient about the life-
style changes necessary after an acute myocardial in-
farction. No mention is made of the patient during the 
time of the acute insult (20). Neuman's model focuses on 
the patient's perception of the illness and is noted to 
be particularly relevant to patients with hypertension 
(21). The core of Orem's self-care nursing model is that 
man has an innate ability to care for himself (22). 
Roy's adaptation model identifies the environment as the 
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source of stimuli to which the person must adapt with 
nursing actions either maintaining or promoting adapta-
tion (23). Hollen proposes a holistic model of health 
which is based on the belief that health is choice (24). 
Guzzetta and Dossey (13) clarify the central concepts of 
the holistic model as one which includes the patient as 
an active participant at all times. The model is also 
inappropriate since concepts of the response to severe 
life-threatening acute trauma have not been validated in 
the intensive care setting where no decisions are made by 
the patient and all decisions are made by the health care 
team for a period often covering many days. 
A review of literature on nursing research in the 
clinical intensive care areas revealed that nursing 
models are not utilized in the theoretical underpinnings 
of the research. Rather, the physiologic response to 
trauma was consistently found as the basis of the re-
searcher's review of the literature. Another assumption 
of this study is that nursing models have not been tested 
in intensive care settings. This was especially evident 
in the coronary intensive care research efforts where 
measurements with Swan-Ganz catheters were used. In burn 
nursing clinical research, the focus tends to be on the 
metabolic alterations which occur as a result of the burn 
injury. 
The consistent practice of conducting intensive care 
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unit physiological research without incorporation into a 
nursing model appears to be due to a temporal gap in 
existing nursing models when no time for, nor means of, 
adaptation occurs. In IeU settings, nurses need to adapt 
to the needs of a helpless, severely-traumatized patient. 
It is only much later that the nurse can work with the 
patient to facilitate adaptation to the magnitude and im-
plications of the illness/injury. 
Purpose 
The purpose of this study was to determine the 
effect of plasma exchange on the pathophysiology of burn 
shock. This research is designed to answer the following 
specific questions: 
1. Is the volume of resuscitation fluid decreased 
in thermally injured subjects when plasma exchange is 
combined with standard fluid resuscitation using the 
Parkland formula? 
2. What is the effect of plasma exchange combined 
with standard burn shock resuscitation using the Parkland 




This chapter presents the theoretical framework of 
the study. The material is organized as follows so as to 
comprise a physiological shock framework. First is an 
overview of the physiologic response to thermal injury 
which includes the cardiovascular, cellular and im-
munologic responses. Second, the factors of pulmonary 
injury and increased evaporative water loss in response 
to thermal injury are presented. Next is a review of the 
principles of fluid resuscitation and the variety of 
formulas currently in use. Then plasmapheresis and its 
current clinical application is discussed. Following 
this is a review of the current use of plasma exchange in 
burn patients. To conclude the chapter, a summary is 
presented. 
Pathophysiological Response to 
Thermal Injury 
Burn shock appears to consist of both a hypovolemic 
and a cellular component. Hypovolemic shock results from 
an increase in capillary permeability which begins with 
the onset of thermal injury and persists for approximately 
24 hours postburn, even when adequate resuscitation fluid 
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is given. Investigators have documented the release of 
many mediators of the inflammatory response which may 
play roles in the cardiovascular response to burns. Evi-
de nee has also accumulated suggesting that cellular me-
tabolism is disrupted with onset of the burn wound 
resulting in altered membrane permeability and loss of 
normal electrolyte homeostasis. This cellular defect may 
be the pathophysiologic process responsible for the gene-
sis of burn shock. Also, the many circulating factors 
demonstrated in burn serum may play a role in the genera-
tion of the cellular abnormalties known to occur. While 
recognizing that the cardiovascular or systemic response 
is intricately interwoven into the cellular response, 
they will nevertheless be discussed as separate entities 
for the purpose of describing their components. 
Cardiovascular Response to 
Thermal Injury 
The end result of a major burn injury is hypo~olemic 
shock. This burn shock is proportional to the depth and 
extent of the injury. Burns involving 25 to 40% TBSA re-
quire cardiovascular support via intravenous fluid but pa-
tients usually tolerate the treatment in a fairly predic-
table manner. Burns involving greater than 40% TBSA are 
potentially lethal injuries which are often accompanied 
by a stormy clinical course. In general, the burn shock 
research model refers to an involvement of 40% TBSA burn 
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or greater. 
Cope and Moore (25) in 1944, were among the first to 
describe the alteration in capillary permeability which 
results in a fluid shift to the interstitium. This was 
measured indirectly in that the fluid content of burn 
blisters was analyzed for protein content and found to be 
protein-rich. Almost simultaneously, Fox and Keston (26) 
in 1945 demonstrated massive redistribution of sodium in 
burned mice, with the sodium content of injured skin and 
muscle greatly increased in proportion to water gain. 
Many further studies were performed in experimental burns 
and in clinical burn treatment to document the magnitude 
of the capillary leak of intravascular fluid into the in-
terstitium. Ganrot et al. (27) demonstrated the 
lymph/plasma ratio of all proteins except that of alpha-
2-macroglobulin increased after experimental scalding of 
dogs, indicating an increased capillary permeability to 
proteins with molecular weights up to 300,000. These 
findings were significant because normally the inter-
stitial fluid is essentially an ultrafiltrate of plasma 
in equilibrium with plasma but containing little protein 
and nearly equal amounts of sodium. Wachtel et al. (28) 
in 1983, used Wick catheters to obtain direct measure-
ments of the interstitial fluid pressures while at the 
same time measuring serum oncotic pressures in six se-
verely burned patients. The study showed no consistent 
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relationship between oncotic pressures of serum and in-
terstitial fluid. Thus, after extensive thermal injury, 
a sequential series of fluid shifts occurs involving the 
redistribution of body water, salt, and protein. The in-
crease in capillary permeability allows the intravascular 
fluid, except for the red blood cells and white blood 
cells, to leak into the interstitial spaces. This re-
sults in a marked decrease in the available circulating 
volume: thus the terminology, burn shock. 
It has long been recognized that cardiac dysfunction 
is also a component of major thermal injury. Burn shock 
is accompanied by a sudden precipitous drop of the car-
diac output which does not parallel the gradual reduction 
of blood volume. Furthermore, the infusion of intra-
venous fluids in amounts to restore the circulating 
volume does not return the cardiac output to preburn 
levels. This was demonstrated in 1957 by Dobson and 
Warner (29) using dye-dilution techniques to measure 
changes in cardiac output, plasma volume, and liver blood 
flow in burned dogs. Their most striking finding was the 
almost immediate and precipitous fall in cardiac output 
not associated in the initial stages with a significant 
reduction in plasma volume. The liver blood flow 
paralleled the decline in cardiac output in this study. 
Merriam (30) in 1962, using ventricular function curves 
as an index of myocardial contractility in burned dogs, 
determined that the burn produced impairment of myo-
cardial contractility but was unable to identify the 
mechanism. Many further studies were performed to 
measure the magnitude of myocardial dysfunction but it 
was not until the early 1970s, with the advent of the 
Swan-Ganz thermodilution catheter, that the full phys-
iologic impact was described. Aikawa et al. (31) in 
21 
1978 presented pulmonary artery catheterization and 
thermodilution cardiac output determinations in 39 criti-
cally burned patients. Their findings included a) pul-
monary artery wedge pressures, which reflect left ven-
tricular function relative to its afterload, were found 
to be a more reliable indicator of circulating volume 
than the central venous pressure which reflects right 
ventricular function, and b) depressed myocardial 
function was present in these patients. 
The consistent burn shock finding of inappropriately 
low cardiac output in the presence of vigorous intravenous 
fluid resuscitation led to the suggestion of a specific 
myocardial depressant factor. Baxter et al. (32) sugges-
ted in 1966 the presence of circulating material capable 
of selectively depressing myocardial function. Their work 
involved cross-perfusion of burned to normal dogs and 
showed a decrease in cardiac output of 45 to 70% in the 
unburned animals occurring within three to five minutes of 
cross-perfusion. Glenn and Lefer (33) in 1971 demon-
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strated that intravenous infusion of isolated myocardial 
depressant factor into intact anesthetized cats in amounts 
equivalent to that present in the plasma of cats in shock 
resulted in a profound shock state 30 to 60 minutes post-
infusion. 
A similar myocardial depressant factor was described 
by Lefer et ale (34) in studies of a hemorrhagic shock cat 
model. They found the substance to be dialyzable and 
therefore of low molecular weight. In addition, a marked 
depression in the contractility of isolated cat cardiac 
muscle when exposed to plasma from cats in late hemor-
rhagic shock was noted. Further work by Lefer and 
Blattberg (35) revealed not only a myocardial depressant 
factor but also a reticuloendothelial depressing factor. 
The source of the myocardial depressant factor 
remained elusive. Lefer and Martin (36) in 1970 suggested 
the pancreas as the primary site of production of the 
precursor of myocardial depressant factor, its activator, 
or the factor itself. Rosenthal et ale (37) suggested 
the burned skin as the source of the factor. After iso-
lating a "toxic factor" from burned skin, its action was 
shown to be primarily on the myocardium. After isolating 
purified burn toxin and its competetin, their data sug-
gested competition for the same myocardial receptor 
sites. Raffa and Trunkey (38) demonstrated even more 
specific effects in a study of the function of rabbit 
interventricular septum depression after myocardial de-
pressant factor exposure. 
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The chemical structure of the myocardial depressant 
factor was characterized by Goldfarb et al. (39) as con-
taining L-leucine, an amino acid which is a demonstrated 
cardiac depressant. And, while most investigators focused 
on the immediate postburn period as the time of maximum 
effect of myocardial depressant factor, DeSantis et al. 
(40) report even greater activity at four to five days 
postburn. 
The gut has also been implicated as the source of an 
endotoxin producing a shock syndrome. Caridis et al. (41) 
discuss persistent shock in nonseptic disorders due to en-
dotoxin. They point out that endotoxin is continuously 
absorbed from the intestinal tract but is promptly cleared 
by the reticuloendothelial system. As mentioned in a pre-
viously cited reference (35) the reticuloendothelial sys-
tem is depressed with shock; thus it is possible that the 
circulating endotoxin accumulates with progressive 
vascular collapse as the consequence. 
Hamer-Hodges et al.(42) in 1974 demonstrated the 
role of intraintestinal Gram-negative bacterial flora in 
major thermal injury by comparing a burned rabbit model 
exposed either to Gram-negative or to Gram-positive exo-
toxin. The shock response was overwhelming in the group 
with exposure to Gram-negative flora but relatively mild 
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in the group with Gram-positive exposure. An additional 
finding was a separate vasoactive agent released from the 
burn into the circulation during a period of several 
hours. This agent was reported to cause a generalized 
increase in vascular permeability which allows the 
transmural movement of living bacteria and endotoxin from 
the intestinal lumen. The burn wound itself was also 
postulated as the source of the vasoactive substance by 
Cuevas et ale (43). Isolation of a substance from the 
venous blood of burned rabbits with a large burn followed 
by its injection into unburned animals produced a capil-
lary leak which then allowed mobilization of endotoxin 
from the intestine. At the same time, Little and Stoner 
(44) failed to find a role for intestinal bacterial endo-
toxin in burn shock. Kremer et ale (45) in 1981 produced 
additional strong evidence for a specific burn toxin 
which has as its source the burned skin and as its action 
direct damage to mitochondria. Their conclusion is that 
one important aspect of burn treatment should be the eli-
mination of the toxic substances if possible. 
In summary, while there is agreement that myocardial 
dysfunction is present with all major burn injuries, the 
etiology of the depression remains to be described except 
in the most general terms. It is now accepted that there 
is no simple specific myocardial depressant factor but, 
rather, a cascade of events which are generally termed 
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the cellular response to burn injury and include both 
metabolic and immunologic factors. These factors 
initiate the cardiovascular sequence of loss of capillary 
seal and subsequent hypovolemic shock. 
Cellular Response to Thermal Injury 
Major trauma effects the entire physiologic system 
but the survival of the patient depends upon its ultimate 
impact at the cellular level. This is as true for major 
burn patients as for any other form of shock-trauma pa-
tient. The cellular response to burn injury will be dis-
cussed in two general categories: Metabolic response and 
immunologic response. 
The basic syndrome is referred to as the "sick cell 
syndrome." Welt et ale (46) were among the first to des-
cribe this phenomenon as a membrane transport defect. In 
1967 their work with erythrocytes in burn and other types 
of patients revealed an alteration in the steady state 
composition characterized by high intracellular concentra-
tions of sodium, a defect in the active transport of this 
cation in the presence of adequate levels of adenosine 
triphosphate (ATP). Rosenthal and Tabor (47) in 1945, had 
reported an elevation of serum potassium in shocked ani-
mals with the source of the potassium being intracellular 
from both traumatized and nontraumatized areas. 
Actual measurement of changes in transmembrane 
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potential of rat skeletal muscle in a hemorrhagic shock 
model was performed by Cunningham et ale (48) in 1971. 
The finding of a consistent depression of transmembrane 
potential difference and a gradual elevation of inter-
stitial potassium in association with prolonged severe 
hypotension parallels the findings by others in burn 
patients. Further work by Cunningham et ale (49) 
measured the resting membrane potential difference of 
skeletal muscle in 26 normal human subjects, seven 
patients with mild illness, and 21 patients with severe 
debilitating medical disorders. As with the animal 
model, the combination of a low resting membrane poten-
tial and a high intracellular sodium concentration in the 
ill patients was found. Shires et ale (50) demonstrated 
the same findings in a group of 22 baboons in hemorrhagic 
shock but they carried the experiment one step further 
and demonstrated that the effects are reversible with 
adequate ~esuscitation measures. Trunkey et ale (51) 
found a marked decrease in primate muscle extracellular 
water and an increase in both intracellular sodium and 
water during hypovolemic shock. In addition, there was 
an associated decrease in resting membrane potential, a 
decrease in amplitude of the action potential, and pro-
longation of both the repolarization and depolarization 
time in association with a decreased muscle intracellular 
potassium concentration. Resuscitation reversed the 
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changes acutely. Trunkey et ala (52) demonstrated that 
these alterations are due to circulating factors rather 
than ischemia. This was done by primate cross-perfusion 
studies with three groups. Group 1 was an ischemic 
model, Group 2 was the control, and Group 3 was the cir-
culating model. Differences between the groups confirmed 
the changes were limited to the circulating cross-per-
fusion animals. 
Cunningham et ala (53) studied the changes in intra-
cellular sodium and potassium content of red blood cells 
in a group of burn patients during the first few hours af-
ter admission. Early sampling of burn patients revealed 
consistently normal red cell sodium levels regardless of 
the extent of the burn (range: 20-95% TBSA). Sayeed et 
ala (54) in their study of the effect of hemorrhagic shock 
on rat hepatic transmembrane potentials, supported the 
concept of hepatic cell volume being regulated by met-
abolically linked sodium extrusion but not by an e~ually 
coupled sodium-potassium pump. This failure of cellular 
energy-related electrogenic sodium extrusion is the sug-
gested etiology of hepatic cell swelling with shock. 
The cellular dysfunction of burn injury extends 
beyond the transmembrane potential disruption and the 
sodium-potassium pump impairment. Turinsky et ala (55) 
suggest that muscles underlying the burn in a rat model 
also show a loss of intracellular magnesium and phosphate. 
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Deets and Glaviano (56) have verified the effect of shock 
on muscle by demonstrating an elevated lactic dehydro-
genase (LDH). Burned dogs showed a marked increase in 
total plasma LDH accompanied by a significant decrease in 
cardiac output and an increase in total peripheral resis-
tance and hematocrit. Their finding of negative myo-
cardial uptake of LDH indicated the cardiac muscle was 
the source of the circulating LDH. 
In summary, the above studies suggest impairment of 
the basic cellular functions such as the sodium-potassium 
pump as the underlying cause of the diminished membrane 
potentials. The data suggest a decrease in the efficiency 
of the pump: a change which can be reversed by adequate 
resuscitation over time. This points to evidence for the 
presence of circulating factors versus ischemic factors. 
Stress reactions to severe trauma also involve the 
response of the sympathetic nervous system and other ho-
meostatic regulators. Catecholamines are found in ele-
vated amounts in both serum and urine of burn patients. 
Okamoto et al. (57) report changes in lipid metabolism 
described as an elevation in plasma free fatty acids (FFA) 
and a decrease in plasma cholesterol and phospholipids si-
multaneously with the elevated catecholamines. Wilmore et 
al. (58) in 1974 conducted in-depth research of 20 burn 
patients and four normal individuals in a metabolic cham-
ber environment for the purpose of studying the hypermeta-
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bolic response to injury. They found all burn patients 
were hypermetabolic at all ambient temperatures and their 
core and mean temperatures were significantly elevated 
above control values. However, burn patients are in-
ternally warm, not externally cold. The metabolic rate 
increased with burn size in a curvilinear relationship, 
with oxygen consumption rarely exceeding two and one-half 
times basal levels. Burn patients treated in a warm en-
vironment (32 degrees C) demonstrated lower metabolic 
rates than when treated in a cool environment (22 degrees 
C). Despite this finding, it is apparent that evapora-
tive water loss and surface cooling in the burn patient 
are not the primary stimulus for the hypermetabolic state. 
These authors found evidence for mediation by catechola-
mines as the etiology of the increased heat production in 
response to a direct effect on cellular calorigenic acti-
vity. Associated injuries in patients with greater than 
40% TBSA burn exert little or no metabolic effect, for 
the thermal injury has already caused a maximal stress 
response. Burn patients were found to have reset their 
thermal regulatory set-point upward. Additional findings 
include: a) fasting blood glucose is above normal levels 
following the injury; and b) the hyperglycemia is related 
to the extent of the injury. Hauben et ale (59) report on 
eight burn patients with concommitant smoke inhalation 
injury, seven of whom demonstrated elevated levels of 
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plasma vasopressin (antidiuretic hormone (AOH)) during 
the shock phase of burn injury. The level of elevation 
was found to be related to the severity of the burn. 
Serum sodium and potassium levels did not show any signi-
ficant alterations. Burn injuries are known to produce a 
sympathetic stress response. The reflex arc mobilizes 
neural and/or hormonal afferent stimuli to the 
hypothalmus. This produces a catecholamine response ma-
nifested clinically as hypermetabolism, hyperthermia, and 
hyperglycemia. 
Evidence also exists that the burn wound itself 
directly mediates the response to injury at both the local 
and systemic level. Wilmore et ale (60) report that the 
body's priority response to injury is the wound itself and 
that the general systemic events appear to occur as if in 
response to tissue inflammation. That is, vasodilation, 
increased capillary permeability, and edema occur to pro-
mote healing. The distribution of the peripheral circula-
tion following thermal injury transports both heat and 
glucose preferentially to the wound. The energy cost of 
these repairative and transport processes is reflected in 
the increased metabolism and hyperdynamic circulation pre-
viously reported by Wilmore et ale (58). The signal for 
the response is unknown since patients whose wounds have 
been denervated continue to have the posttraumatic metabo-
lic response. Gump et ala (61) also analyzed blood flow 
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and oxygen consumption in patients with severe burns. 
They found that the extensive evaporative heat loss char-
acteristic of burn patients is met, at least in part, by 
increased visceral heat production. Analysis of the data 
suggested that peripheral blood flow was increased beyond 
metabolic tissue requirements. 
Studies describing the effect of injury and infection 
on visceral metabolism and circulation were also performed 
by Wilmore et ala (62). Thirty-one burn patients were 
studied to characterize the role of the liver and kidney. 
Seven of the patients were in the early phase of burn in-
jury and all demonstrated splanchnic uptake of lactate and 
pyruvate greater than normal. Assuming complete hepatic 
conversion of lactate and pyruvate to glucose, these two 
substrates accounted for 30 to 50% of the glucose produced 
by the liver. The study showed that hepatic glucose pro-
duction increases following thermal injury. 
Hypothalamic function alterations following thermal 
injury were evaluated by Wilmore et ala (63) to determine 
the role of the central nervous system in directing the 
metabolic response to injury. Nine burn patients were 
studied in an environmental chamber and were found to have 
elevated human growth hormone (HGH) serum levels in the 
presence of hyperglycemia. Since HGH is normally sup-
pressed by hyperglycemia, it is suggested that the injury 
produces an alteration in hypothalamic function which aug-
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ments HGH elaboration at the same time it increases sympa-
thetic discharge. 
The relative significance of thermal and metabolic 
demands on burn hypermetabolism was evaluated by Aulick et 
ale (64) by studying 20 burn patients and five normal con-
trols in an environmental chamber. They found that the 
hypermetabolic rate is not decreased during rest, sleep, 
or warmth in burn patients. Since the increased oxygen 
consumption could not be accounted for on the basis of the 
elevated body temperature alone, it was concluded that an 
elevated metabolic state, and not a thermoregulatory 
drive, is responsible for the increased heat production. 
Glucose and lactate kinetics are also altered fol-
lowing burn shock. While tissue hypoxia produces lactic 
acidosis, its persistence in the presence of adequate tis-
sue perfusion suggests an increased rate of glycogenoly-
sis. Wolfe et ale (65) in a study on a guinea pig model, 
found the percentage of gluconeogenesis originating from 
lactate was elevated postburn. Wilmore et ale (66) in a 
discussion of glucose metabolism, report that an absolute 
or relative insulin deficiency in combination with an ex-
cess of glucocorticoid, glucagon, and/or catecholamine are 
the signals which promote gluconeogenesis. In the early 
burn phase, insulin concentrations are low but then rise 
toward normal with resuscitation. The hyperglycemia is a 
result of increased hepatic glucose production. The cel-
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lular components of the injured tissue utilize glucose as 
their primary fuel and convert this sugar to lactate which 
is recycled to the liver and reprocessed to new glucose. 
Evidence of hepatic response to injury is also char-
acterized by alterations of the clotting factor. Burn pa-
tients are often classified as "hypercoagulable" in that 
plasma fibrinogen concentration is elevated while pro-
thrombin time (PT) and activated partial thromboplastin 
time (PTT) are shortened. McManus et al. (67) studied the 
syndrome of disseminated intravascular coagulation (DIC) 
in burn patients. The syndrome results in incoagulability 
(PT, PTT), clotting factor consumption (Factors V, VIII, 
platelet count), and a resultant secondary fibrinolysis. 
A review of 274 burn patients revealed that five went on 
to develop clinically documented DIC. Baxter, in discus-
sing this paper, reports laboratory findings reflecting 
progressive thrombocytopenia in conjunction with elevated 
fibrin split products and fibrinogen, as "normal" findings 
in 100 patients with 30% or greater TBSA burns. 
In summary, extensive thermal injury initiates the 
most marked alterations in body metabolism associated with 
any illness. Much of the work explaining this response 
has been conducted by Wilmore and Aulick (3) who report 
the persistent tachycardia, hyperpnea, hyperpyrexia, and 
marked body wasting seen in the burn patient reflects 
heightened metabolic activity and accelerated body catabo-
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lism. These systemic alterations occur as a result of 
the cutaneous inflammatory process and are thought to 
facilitate wound repair. The neural component of this 
alteration is in response to a sympathetic reaction which 
releases catecholamines and vasopressin in large amounts. 
Immunologic Response to Thermal Injury 
The immunologic response to burn injury is im-
mediate, prolonged, and severe. The end result in pa-
tients surviving burn shock is an increased suscepti-
bility to potentially fatal systemic burn wound sepsis. 
Alexander and Moncrief (68) reported in 1966 thermal in-
jury results in a susceptibility to infection which con-
tinues to be the greatest single cause of death in 
patients surviving the initial shock. This discussion 
will be limited to the immunologic changes associated 
with the shock phase. 
The role of these circulating factors in the genera-
tion of burn shock has been extensively studied. Serum 
or plasma from burned subjects has since been shown to 
induce a variety of phenomena associated with the burn 
state. Warden et al. (69) in 1974, evaluated leukocyte 
chemotaxis in vitro in 46 thermally injured patients. 
During the first 72 hours postburn, all patients demon-
strated a decrease in leukocyte migration with the de-
crease inversely correlated with burn size. A further 
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study by the same group and reported in 1975 assessed the 
effect of normal serum upon burn-suppressed leukocytes 
and the effects of three commonly used topical chemo-
therapeutic agents upon the chemotaxis exhibited by 
granulocytes from normal controls (70). They found that 
placing the burn-suppressed leukocytes into serum ob-
tained from normal donors returned the levels to 107% of 
normal activity. Additionally, burn serum was demon-
strated to suppress normal leukocytes from unburned 
donors. The use of commercially available albumin did 
not restore chemotactic function. Both mafenide and sil-
ver sulfadiazine suppressed the chemotactic function of 
granulocytes obtained from normal controls. Further work 
by Miller and Baker (71) reports suppressive mononuclear 
cells are at least partially responsible for the de-
creased immunocompetence of burn patients. Ninnemann 
(72) reported the participation of both a serum-borne 
factor and a specific subset of B lymphocytes in the 
generation of such suppressor cells. Moreover, he has 
demonstrated the presence of prostaglandins, endotoxins, 
and interferon in the sera of thermally injured patients 
and suggests that these substances may be responsible for 
the above described phenomenon. Ninemann et ale demon-
strated that lymphocyte function is compromised in the 
presence of burn sera (73). Rapaport and Bachvaroff (74) 
report that thermal injury is associated with significant 
enhancements in the rate of generation of antibody-
forming cells in response to T cell dependent antigens 
and that the effect is most pronounced in mice immunized 
within 24 hours postburn. 
Altered white blood cell (WBC) superoxide activity 
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was reported by Edgar et ale (75) when cells were incubated 
in burn serum. Loebel et al. (2) reported markedly 
shortened red blood cell (RBC) survival and an increase 
in RBC destruction when normal RBCs were placed in burn 
patients. A return to normal longevity of the RBCs was 
noted when the cells were placed into normal individuals. 
From these studies it can be concluded that, although 
thermally injured patients demonstrate altered leukocyte 
function, these abnormalities can be returned to normal 
when the leukocyte is removed from the burn environment. 
A host of chemicals found to be present in burn plas-
ma in altered concentrations may playa role in burn 
shock. These include vasoactive amines (histamine, sero-
tonin), products of complement activiation (C3a, C5a), 
prostaglandins, kinins, endotoxin, and the metabolic hor-
mones (catecholamines, glucocorticoids). 
Heideman et ale (76) have demonstrated a decrease in 
the complement components C3a and C5a in the circulation 
following thermal injury and suggest that the injury non-
specifically activates the complement system. Activation 
of complement in the injured tissue results in an inflam-
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matory response due to the release of histamine and sero-
tonin by C3a and C5a. This appears to alter capillary 
permeability, leading to edema formation. Gelfand et al. 
(77) found pre rential activation and depletion of the 
alternative complement pathway in eight adult burn pa-
tients. The alternative pathway titer was reduced by more 
than 90%, suggesting preferential depletion of this 
pathway. 
A consumptive opsoninopathy has been reported by 
Alexander et al. (78). While normally opsonin renders 
bacteria susceptible to phagocytosis, this study showed 
reduced ability of a group of patients' serum to opsonize 
bacteria. Bjornson et al. (79) likewise found consumption 
of C3, properdin, and Factor B following thermal injury 
and suggested a consumptive opsoninopathy had occurred. 
They were able to demonstrate that burn serum contained an 
inhibitor of C3 conversion which would lead to decreased 
opsonization and polymorphonuclear (PMN) neutrophil 
function. 
The vasoactive amines (histamine and serotonin) 
initiate the inflammatory response along with kinin 
polypeptides and other chemical mediators (80). As a 
result of these vascular changes, fluid and fibrinogen 
leave the dilated, permeable vessels. Prostaglandins 
function in the inflammatory process by regulating the 
metabolism of the cells of inflammation (lymphocytes, 
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macrophages, and neutrophils). In addition to the release 
of effector substances, burn injury has be~n shown to 
cause platelet consumption and activation; release of 
thromboxanes; and inhibition of heart muscle contraction. 
Studies into the pharmacologic alteration of the 
histamine-serotonin release have been performed by Markley 
et ale (81) and Holliman et ale (82). Markley found that 
preinjury doses of purines and histamines produced an 
increased blood volume and lower hematocrit values after 
burning of mice. The mechanism remains obscure but two 
possibilities appear feasible: a) vasoconstriction 
decreased fluid loss into the interstitium, or b) the drug 
increased fluid loss at the site of injection, where it 
was held while fluids were lost at the site of injury, and 
then returned it to the circulation after the fluid loss 
due to injury had reached its peak. Holliman evaluated 
the effect of ketanserin, a specific serotonin antagonist, 
on burn shock in a pig model and found the ketanserin-
treated groups demonstrated improved cardiac index, de-
creased pulmonary artery pressures, and smaller arterio-
venous oxygen content differences compared to the control 
group. Donati et al.(83) have reported on the marginal 
effectiveness of the administration of the immunomodula-
ting agents methysoprinol and timostimoline in partially 
restoring neutrophil function. Ishizawa et ale (84) have 
used thymosin to reverse the T lymphocyte depression seen 
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acutely postburn. 
Another management approach is to alter the internal 
burn environment. In altering the environment, treatment 
possibilities include either plasmapheresis or hemodialy-
sis to remove the various circulating toxins. Warden et 
al. (85) have presented preliminary results using plasma 
exchange therapy in 21 patients not responding to conven-
tional burn management. Plasma exchange was initiated 
for a) fluid resuscitation failure, b) massive myo-
globinuria following electrical injury, c) metabolic ex-
haustion, d) acute respiratory distress syndrome fol-
lowing delayed resuscitation, and e) documented sepsis. 
In all patients, clinical values returned toward normal 
as a result of plasma exchange. Among the 5 groups, the 
most spectacular results were seen in the inadequate re-
suscitation group. Preliminary work by Ninnemann(80) in 
the same group of patients suggests that this procedure 
also corrects at least some postburn immunologic prob-
lems. A brief report by Baxter(85) utilizing exchange 
transfusion in pediatric burn patients not responding to 
conventional fluid volumes showed reversal of the fluid 
requirements toward normal resuscitation volumes. 
The significance of adrenal hormones in response to 
burn injury has been detailed in a case study by stratta 
et al. (86) of an adrenalectomized patient. This 29 year 
old white male's past medical history was remarkable for a 
bilateral adrenalectomy performed 13 years earlier for 
presumed Cushing's disease. Since that time he had been 
maintained on replacement corticosteroids. The patient 
presented with a 35.5% TBSA burn, 3.5% of which appeared 
to be full-thickness. He also had a serious inhalation 
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injury confirmed by Xenon perfusion scan. This pa-
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tient demonstrated an inadequate response to fluid resus-
citation and excessive third-space fluid losses, defective 
thermogenesis, profound nutritional abnormalities, im-
paired wound healing, and compromised immunologic 
function. The patient was discharged 114 days following 
injury with nearly complete burn wound closure and normal 
range of motion in all extremities. 
Pulmonary Factors in the 
to Thermal Injury 
There are two physiologic mechanisms responsible for 
the pulmonary response to burn injury. The first is in 
response to the hypermetabolism of burn injury and the se-
cond is in response to the direct trauma of an inhalation 
injury. Petroff et al.(87) report that uncomplicated burn 
patients have a minute ventilation twice that of healthy 
normal subjects. This hyperventilation is in large part 
due to the increased metabolic demands of the burn patient 
since oxygen consumption has been shown to be as much as 
twice basal levels. 
The second component is due to inhalation of noxious 
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products of combustion. The damage is not from heat, since 
air is cooled by the time it reaches the bronchus unless 
live steam is inhaled. Inhalation injury refers to direct 
insult at the alveolar level secondary to chemical fume or 
smoke inhalation. The subsequent response involves inter-
stitial edema as the inflammatory process is initiated. 
The edema is a diffusion defect which prevents the passage 
of oxygen across the lung. No immediate clinical signs or 
symptoms are evidenced except by history. The injury 
manifests itself as acute respiratory distress syndrome 
(ARDS) at 48 to 72 hours postinjury. The initial chest 
radiograph and arterial blood gas values will be within 
normal limits. The edema is progressive and, since the 
lungs have a total surface area of approximately 70 
square meters in an adult (88), the amount of sequestered 
fluid can be three to five liters. The severity of the 
injury is proportional to the concentration and duration 
of contact with the noxious agent and is in no way corre-
lated with the extent of the TBSA burn. Diagnosis is 
made by 133-Xenon lung scan and/or fiberoptic broncho-
scopy. 
Moylan et al. (89) evaluated the use of 133-Xenon in 
measurements of both the perfusion and the diffusion-
ventilation phases of pulmonary function in 50 burn pa-
tients. They found uniform agreement between the 133-
Xenon scan diagnosis of inhalation injury and patholo-
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gical finding. The mortality rate in burn patients with 
inhalation injury is higher than in those patients with 
either injury alone. This series of patients had a 60% 
mortality. 
Moylan et ale (90) studied a group of 25 burn pa-
tients undergoing fiberoptic bronchoscopy for the purpose 
of diagnosing inhalation injury. The positive finding of 
injury in 15 of the 25 patients studied revealed the use-
fulness of this technique. Three of the patients with 
airway injuries had skin burns of less than 5% TBSA. At 
the time of admission, only two patients had symptoms of 
ARDS. 
Evaporative Water Loss as ~ Factor in 
the Response to Thermal Injury 
One of the major purposes of intact skin is to serve 
as a barrier to evaporative water loss from the body. 
With major burn injury, this ability of the skin to regu-
late evaporative water loss is totally disrupted. In 1962 
Moncrief and Mason (91) attempted to determine the magni-
tude of such a loss. They reported that the use of the 
parameter of insensible weight loss in burn patients had 
previously been used as an approximation of insensible wa-
ter loss. Using the same parameter and a scale with an 
accuracy of ~ 50 g, 19 patients were studied over four 
hour time periods. The data revealed evaporative water 
loss to be extensive in burned patients, being in the 
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range of 20 times normal in the early phase of injury and 
gradually decreasing as wound closure was achieved. 
Later studies by Wilmore et al. (58) report that while 
present, the evaporative water loss and surface cooling 
in the burn patient is not the primary stimulus for burn 
hypermetabolism but rather, the hypermetabolic response 
is related to endogenous metabolic activity. Vaporiza-
tional heat loss is a route of transfer of this excess 
heat from the body. The insensible water loss through 
the skin is not from evaporation of water from sweat 
glands but from water vapor formed within the body and 
lost through the skin (92). 
Calculation of the amount of fluid lost via evapora-
tive water loss includes losses from all sources. While 
normally the skin is the major source of insensible loss 
(75%) and the lungs are minor sources (25%), the amount is 
only about 600-800 ml per day. This changes dramatically 
with burn shock because not only does the skin's loss in-
crease but so does the lung loss. Hypermetabolism and hy-
perventilation, especially in an intubated patient, may 
result in losses up to 1.5 L/day. Replacement of the los-
ses is mandatory to prevent volume deficit. Moncrief (93) 
reports a minimum of 2,000 mL/day is necessary for basal 
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requirements, and in larger burns 100 to 150 mL/m BSA/ 
hour is average in adults. The actual criterion for 
evaluation is a serum sodium of 130 to 140 mEq/L since a 
level below 130 mEq/L represents overhydration and above 
140 mEq/L represents dehydration. 
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Each gram of evaporated water removes approximately 
0.58 kcal of heat from the body. If thermal neutrality is 
to be maintained, the metabolic rate of the patient must 
increase to replace the lost heat. This may be accom-
plished, in part, by the shivering seen in burn patients. 
This increased heat need may be as much as 3,000 kcal per 
day over normal levels. The energy expended for such an 
increased demand would reduce that available for other 
metabolic functions. Harrison et ale (94) in 1964, 
measured simultaneously the insensible water loss and the 
metabolic rate of 21 patients with burns of varied se-
verity. A strong relationship was found between insensi-
ble loss and percent TBSA burn irrespective of whether 
the wound was partial- or full-thickness. Both types of 
burns are equally poor barriers to water loss during the 
early postburn period. This study reported a total water 
loss, including urine, insensible loss, and exudate as 
2.0 to 3.1 mL/kg/% burn. Roe and Kinney (95) report the 
evaporative water loss in two patients with 50% TBSA burn 
as about 5 L/daYi this is an expenditure of 2,880 
kcal/day merely to maintain a stable body temperature. 
They also report the serum sodium level as the most sen-
sitive index of water balance. Birke et ale (96) 
measured evaporative water losses exceeding 7 L/day in a 
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group of 17 burn patients with the highest losses occur-
ring during the first days after injury. During the ini-
tial stage, fluid was lost directly as exudate from the 
wound as well as via increased evaporation from the in-
jured epithelium. Lamke and Liljedahl (97) studied 16 
burn patients and found that evaporative water loss from 
normal, intact skin in burn patients was not altered. 
First degree burns emitted as little water as normal 
skin. Thus, in calculating fluid requirements, areas of 
partial- and full-thickness injury are the basis of the 
formula. Lamke (98) also reports that evaporative water 
loss can be minimized by maintaining environmental condi-
tions at a warm (32 degree C) and relatively humid (25%) 
setting. The patient's core body temperature should be 
maintained at 38 degrees C and shivering avoided. 
Zawacki et ale (99) report that application of a water-
proof film to the burn wound was associated with a marked 
reduction in insensible weight loss but no significant 
change in the elevated metabolic rate. Carnes et ale 
(100) report increased evaporative water loss as a phe-
nomenon which continues even after the wound is clinical-
ly healed. 
The cumulative information on evaporative water loss 
made it apparent that the loss was of significant clinical 
importance. Only by the administration of large volumes 
of fluid could the burn patient maintain fluid balance. A 
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formula was developed for the purpose of estimating the 
volumes of fluid which might be required to replace eva-
porative water loss (see page 89 for further discussion). 
The type of fluid administered depends upon the patient's 
serum sodium content, acid-base balance, general electro-
lyte status, and renal function. The route of fluid ad-
ministration depends upon the patient's ability to ingest 
fluids, either orally or via an enteral feeding tube to 
the duodenum, after resolution of the paralytic ileus as-
sociated with major thermal injury. Initially, all fluid 
is administered by the intravenous route. 
Resuscitation of Burn Shock 
Burn shock and its associated hypovolemia have been a 
recognized component of burn care since 1930. The princi-
pIes of burn shock therapy have been aimed at supportive 
rather than therapeutic interventions; that is, the goal 
of treatment is to support the patient's cardiovascular 
system with large volumes of fluid until burn shock 
ceases. This treatment, while usually effective, is not 
effective for all patients. A 1980 survey of burn survi-
val by Curreri et ale (101) reports that 15% of 75 deaths 
in a population of 937 burn patients were the result of 
irreversible burn shock. Baxter (102) in 1981 reported 
on 954 patients with 54 deaths occurring in the first ten 
days postburn. Thirty-two of the 54 patients died within 
the first 24 hours postburn and 37 died within the first 
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48 hours. Sevitt (103) in 1972, reported 12% of 156 burn 
deaths as due to early shock or cardiac failure. Deaths 
due to burn injury represent a significant societal prob-
lem since Artz and Yarbrough (104) report there were 7,645 
deaths due to burn accidents in the United States in 1960. 
The extent of the TBSA involved is the single most impor-
tant factor influencing prognosis and treatment. Baxter 
(105) states patients with zero to 20% burns do not have 
to be resuscitated at all. With most burns in the physio-
logic age range, between 20 and 35% volume restoration of 
almost any kind, so long as it contains electrolytes, will 
suffice. Where optimal resuscitation, which Baxter de-
fines as restoration of all physiologic systems at the 
earliest possible time, becomes critical is in the 35 to 
60% burn. In burns exceeding 65% TBSA, other factors in-
fluence ultimate survival. 
There are two components to fluid resuscitation for-
mulas: The volume/time and the chemical content of the 
fluid administered. Caldwell(106) states that almost any 
solution containing sodium will serve to adequately resus-
citate young and healthy patients. This fact does not 
help to define the ideal salt and water combination. The 
need for fluid has been well-established since death soon 
occurs in patients with large burns but without admini-
stered fluid. Leape (107), in assessing the volume/time 
factor, reported that the initiation of early fluid resus-
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citation improved survival in a rat study. untreated rats 
with a 50% TBSA burn all died by 24 hours, 92% by 12 hours 
postburn. Mean survival time in untreated animals was 7.4 
hours. The administration of fluid at four hours improved 
survival time but was less than half the effect of giving 
fluid within the first hour. Animals given 30% body 
weight of fluid did better than those given 20%. 
Recognition of the necessity for large volumes of re-
suscitation fluid has resulted in a great decrease in the 
early mortality of burn patients. Since the 1940s, formu-
las for burn resuscitation have been based on several 
pathophysiologic observations. First, immediately fol-
lowing thermal injury, there begins a rapid leakage of 
fluid from the vascular space into the interstitium. This 
fluid loss is greatest during the first six to eight hours 
postburn, after which it gradually declines so that by 24 
to 36 hours postburn, capillary integrity is generally 
restored. While capillary leakage following minor burns 
in localized to the wound area, burns involving greater 
than 25% TBSA result in systemic leakage and total body 
edema. Isotope dilution studies (26) have demonstrated 
loss of up to 50% of the effective extracellular fluid 
(ECF) volume during unresuscitated burn shock (5). The 
initial disruption of capillary integrity permits even 
large protein molecules to permeate freely into the inter-
stitium (27). For this reason, colloid-containing resus-
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citation solutions are usually withheld until the restora-
tion of capillary integrity at 24 to 36 hours postburn, at 
which time colloids may be effective in reexpanding the 
vascular compartment. The key ingredient of all resusci-
tation fluid appears to be the sodium ion, and various re-
gimens have been shown to be effective in treating burn 
shock in proportion to their sodium content. Bull (108) 
reports there are several successful fluid regimens 
varying greatly in sodium content, both absolutely and rel-
atively to water. The underlying problem remains that 
the circulatory volume needs to be maintained in spite of 
a continuing leak. When the volume is replaced as free 
water, water intoxication occurs. It is now known that 
sodium enters cells as the sodium-potassium pump becomes 
dysfunctional. This theoretically explains the tremen-
dous salt load necessary in the burn shock period to pre-
vent hyponatremia. In addition, Moncrief (109) reports a 
precipitous drop in cardiac output, to about 50% of 
resting normal values, precedes any measurable change in 
blood or plasma volume. Thus, the time after injury when 
cardiovascular support is necessary for survival is far 
shorter than would be expected based on the factor of 
capillary permeability alone. Moylan et ale (110) showed 
that the untreated burn dog model had cardiac outputs of 
30% of normal by six hours postburn. This study also 
found the sodium dosage and the water dosage of resusci-
tation fluids to be independent determinants of early 
restoration of cardiac output. 
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The clinical criteria for the amount of fluid admini-
stered is urine output. Pruitt (Ill) is in agreement with 
other sources when stating the resuscitation fluid regimen 
is adjusted to obtain 30 to 50 mL of urine per hour in the 
burned adult. Greater hourly urine outputs are achieved 
at the expense of additional edema formation. 
There are many resuscitation formulas. The first 
established formula was the Evans formula, followed by 
the Brooke formula. The one most widely used at the cur-
rent time is the Parkland formula. The hypertonic saline 
method is used in some institutions as is the hypertonic, 
albuminated fluid-demand (HALFD) method. A British 
model, the dextran saline method or Mount Vernon formula, 
has also also been used in some burn centers. As reported 
by Baxter et ale (112), the various regimens have in com-
mon an almost identical quantity of isotonic volume for 
each percent TBSA of injury. However, they differ widely 
in the ratio of colloid to crystalloid volumes and in the 
time intervals recommended for effective administration. 
Burn shock differs from other types of hypovolemic shock 
in that it is primarily due to a loss of plasma rather 
than whole blood. In fact, hemoconcentration occurs as 
the less viscous fluid exits and leaves behind only red 
blood and white blood cells. 
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The hourly rate of fluid replacement depends on the 
specific resuscitation formula used to treat the patient. 
But, as Rogenes and Moylan (113) report, the formula is 
only a guideline. Observation of the patient for signs of 
fluid deficit or overload and electrolyte imbalance, com-
bined with an understanding of the physiological conse-
quences of thermal injury is essential for the nurse to 
regulate the fluid replacement. For, while the basic 
fluid therapy in major burns is prescribed by the physi-
cian, the amount of fluid administered each hour becomes a 
nursing deoision. 
The Evans formula (114) is a crystalloid and colloid 
formula with both products being given throughout the 48 
hour period postburn. The formula was derived from a pro-
spective resuscitation study of 68 burn patients. During 
the first 24 hours, colloid in the form of dextran 70 in 
normal saline solution is administered at the volume of 1 
mL/kg/% TBSA burn/24 hours along with the crystalloid in 
the form of normal saline at a volume of 1 mL/kg/% TBSA 
burn/24 hours. In conjunction with this, the patient is 
given 2,000 mL of 5% dextrose in water (D5W) over the 24 
hour period. Half of the fluid is given in the first 
eight hours postburn and the other half is given over the 
subsequent 16 hour period. In the second 24 hours, the 
colloid and crystalloid are given at a rate of 0.5 mL/kg/% 
TBSA burn/24 hours with the amount of maintenance fluid 
S2 
remaining at 2,000 mL of DSW over the 24 hours. The maxi-
mum calculated burn is to be SO% TBSA. 
The Brooke formula (lIS), which is also a crystalloid 
and colloid formula, is a modification of the Evans formu-
la. The colloid is administered in the form of plasma at 
a rate of O.S mL/kg/% burn/24 hours. The crystalloid, in 
the form of lactated Ringer's solution, is administered at 
a volume of 1.5 mL/kg/% burn/24 hours along with mainte-
nance water of 2,000 mL D5W over 24 hours. Half of the 
fluid is given in the first eight hours and half during 
the next 16 hours. During the second 24 hours, the col-
loid is administered at a volume of 0.25 mL/kg/% TBSA/24 
hours and the crystalloid at 0.7S mL/kg/% TBSA burn/24 
hours. The maintenance water volume remains at 2,000 
mL/24 hours. The maximum burn size to be calculated is 
SO% TBSA. 
Hutcher and Haynes (116), in comparing the two 
formulas find the difference to be mainly in the ratio of 
crystalloid to colloid, the Evans being 1:1 whereas the 
Brooke is 3:1. Both formulas require similar amounts of 
sodium and both use SO% TBSA as the maximum calculated 
burn. ReekIer and Mason (117) evaluated the records of 50 
burn patients resuscitated with the Brooke formula and 
found that while this formula satisfactorily predicted the 
clinically required volume administration in burns smaller 
than SO%, larger burns on the average required in excess 
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of the predicted amounts. 
The Parkland formula (4) utilizes Ringer's lactate at 
a volume of 4 mL/kg/% TBSA burn for 24 hours postburn. No 
colloid is administered. One half of the fluid is given 
in the first eight hours postburn and the second half is 
given over the subsequent 16 hours. The calculation is by 
absolute percent of burn with no IImaximum calculation. 1I 
In the second 24 hours, D5W is administered at a rate to 
maintain the serum sodium at 140 mEq/L. Plasma is given 
between 24 and 30 hours postburn in the following amounts: 
40-50% burn, 250 to 500 mL: 50-70% burn, 500 to 800 mLi 
and greater than 70% burn, 800 to 1,200 mL with rapid in-
fusion (118). Baxter (119), in a retrospective analysis 
of 438 adult burn patients, found the formula to accurate-
ly predict the fluid requirements at 4 mL (+0.3 mL)/kg/% 
TBSA burn/24 hours in 70% of the cases. The use of 
Ringer's lactate rather than the previously reported nor-
mal saline was of concern in that it could theoretically 
aggravate the existing lactic acidosis of shock. Canizaro 
et ale (120) performed 639 lactate and pyruvate determina-
tions in 84 patients resuscitated with Ringer's lactate. 
The findings included a significant decrease in lactate 
and excess lactate levels and a return toward normal of pH 
and base excess values during the period of shock while 
Ringer's lactate solution was being infused. 
The amount of edema formation with the previously 
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discussed formulas is massive. Efforts to deliver the re-
quisite salt in a smaller volume of water resulted in the 
development of a hypertonic resuscitation formula. The 
fluid used contains 250 mEq of sodium/L and is admin-
istered during the first 24 hours at a rate to maintain 
urine output at 30 to 40 mL/hour. In the second 24 
hours, one-third isotonic salt solution is administered 
orally. No colloid is given during the 48 hour period. 
If possible, the isotonic salt solution is administered 
orally; either way, fluid intake is restricted to 3,500 
mL in the second 24 hours. Monafo et ale (121) report 
that the initial hypertonic sodium solution contained 300 
mEq sodium/L but that this caused hypernatremia with 
serum sodium levels greater than 165 mEq/L and alkalosis. 
Subsequently, the solution is now intended to contain 250 
mEq/L of sodium, 150 mEq/L of chloride, and 100 mEq/L of 
racemic lactate. Moylan et ale (122) compared hypertonic 
lactate saline solution with isotonic resuscitation ac-
cording to the Brooke formula in a dog model and found 
that the hypertonic resuscitation produced natriuresis 
and no gain in weight. Shimazaki et ale (123) measured 
body fluid changes during hypertonic lactated saline 
(HLS) solution therapy for burn shock in 12 patients com-
pared to 26 patients receiving Ringer's lactate and col-
loid solutions. While finding that the total infusion 
volume during the first 48 hours postburn in the HLS 
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group was only one-half to two-thirds of the other group, 
the intrinsic complications of hyperosmolarity and hyper-
natremia were of clinical significance. Caldwell et ale 
(124) treated 13 burn patients with a solution containing 
300 mEq/L of sodium, 100 mEq/L of chloride, 200 mEq/L of 
lactate, and an osmolality of 600 mosm/L. The total 
volume of fluid given in the first 48 hours was 23% less 
and the sodium load administered 86% greater than would 
have been given using the Brooke formula. All patients 
developed hypernatremia and increased serum osmolality. 
Fox (125) administered solutions containing from 75 to 
300 mEq/L of sodium in various dosages to scalded mice 
and found a wide range of solutions was effective. The 
most effective solution appeared to be composed of 225 
mEq/L of sodium. Hypotonic solutions were less effective 
at all dosage levels. 
A modification of the hypertonic resuscitation is the 
use of a hypertonic, albumin-containing fluid demand regi-
men (HALFD). This method, as described by Jelenko et ale 
(126), consists of a resuscitation fluid composed of a 240 
mosm/L hypertonic fluid plus 12.5 giL of albumin. A com-
parison between randomly selected groups of burn patients 
resuscitated using hypotonic fluid alone, hypertonic fluid 
alone, or hypertonic plus albumin resulted in the latter 
group requiring smaller amounts of resuscitation fluid. 
The parameter evaluated was mean arterial pressures. 
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A British formula for fluid resuscitation (127) re-
ports a formula calculated upon (percent TBSA burn x 
weight in kg) divided by 2. This volume is given in each 
of the following successive periods: four hours, four 
hours, four hours, six hours, six hours, 12 hours over 
the first 36 hours postburn. This formula, the Mount 
Vernon formula, recommends the use of reconstituted dried 
human plasma as the main transfusion fluid (128). Al-
though the fluid of choice is plasma, Dextran 70 in nor-
mal saline or Hartmann's solution can be used if neces-
sary. The goal is 50 to 100 mL/hour of ~rine output. 
This formula is predictive of much less total volume than 
any other currently used formula. 
Hall and Sorensen (129) treated 43 patients for burn 
shock by fluid resuscitation using a dextran saline solu-
tion in 21 patients and Ringer's lactate in 22 patients. 
They found the volume of fluid intake over the first 48 
hours was the same in both groups. Hemoconcentration was 
much greater in the Ringer group, but acid-base balance 
was restored to normal more rapidly than in the dextran 
group. No clinical differentiation could be made between 
the progress of the patients in the two groups. 
It becomes apparent that in the clinical setting 
there are a variety of fluid resuscitation formulas which 
enable clinicians to bring patients through burn shock. 
All formulas stress that they are guidelines only; the 
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hourly volume of fluid administered is determined by the 
clinical parameter of urine output and that is kept to a 
minimum of 30 to 50 mL/hour. Even so, the volumes of 
fluid administered are extremely large. For example, the 
Parkland formula of resuscitating a 70 kg patient with a 
50% TBSA burn would predict a fluid need of 14,000 mL in 
the first 24 hours postburn. Patients with burns greater 
than 60% TBSA may require 20 to 30 L of intravenous fluid 
during the first 24 hours. The hypovolemic burn shock is 
the problem but the iatrogenic complications are also a 
problem. The massive edema associated with burn shock 
resuscitation can lead to mechanical airway obstruction 
necessitating tracheal intubation, increased severity of 
the interstitial pulmonary injury associated with inhala-
tion injury, prolonged ileus with bowel wall edema, com-
promised circulation to the extremities necessitating 
escharotomy or fasciotomy, and to a rapid depletion of 
serum protein with resultant lowered albumin levels. In 
addition, edema has been demonstrated to impair wound 
healing secondary to decreased oxygen tension at the cel-
lular level. At the end of the resuscitation period, 
mobilization of fluid can cause cardiac congestion and 
pulmonary edema. In addition, a major cause of mortality 
in patients with very large burns is failure to resusci-
tate. 
These reported investigations reveal that the in-
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ternal milieu in which various cellular components of the 
body must exist is drastically altered following thermal 
injury. Although thermally injured patients demonstrate 
altered cellular function, these abnormalities can be re-
turned to normal when the cell is removed from the burn 
environment. Clinically it is impossible to remove these 
cells; thus, therapeutic intervention has to be aimed at 
returning the burn environment to normal. This concept 
indirectly supports the use of plasma exchange as poten-
tially beneficial in removing circulating toxic sub-
stances thereby returning the cellular environment toward 
compatibility with homeostasis. 
Plasmapheresis as ~ Therapeutic 
Intervention 
The removal of plasma and the return of cellular 
components of the blood was first described by Abell et 
ale in 1913 to relieve uremia in bilaterally nephrec-
tomized dogs (7). The term pheresis derives from a Greek 
word, aphairesis, which means "taking away (6)." 
Although the procedure is commonly referred to as plasma-
pheresis, plasma exchange is a better term for the pro-
cedure as used in burn patients since the volume of re-
moved plasma is replaced with an equal volume of fresh 
frozen banked plasma. In the past, small scale whole 
blood exchange was carried out using manual exchange. 
During the Twentieth Century, this technique of whole 
59 
blood exchange revolutionized the management of hemolytic 
diseases of the newborn. Ten years have elapsed since 
the introduction of in vivo blood cell separators into 
clinical medicine. These machines were initially de-
veloped for the collection of granulocytes and platelets 
from normal donors; however, their availability in gen-
eral hospitals has led to their therapeutic use in a wide 
range of medical conditions. Current technology now al-
lows two liters of plasma to be exchanged per hour. 
Linker (130) describes a plasmapheresis procedure as 
performed on a continuous flow cell separator. Blood is 
removed from a patient and anticoagulated with a citrate 
solution. The blood then enters a centrifuge and is 
separated into cellular components and plasma. The cel-
lular components are returned to the patient along with 
the replacement fluid of choice. The plasma is collected 
in a reservoir. The amount of the large-volume plasma 
exchange is a factor which has to be individualized to 
each patient. Plasma volume in humans is normally 40 
mL/kg of body weight. By exchanging increasing numbers 
of plasma volume, Linker reports an intravascular marker 
will be depleted to an increasing extent (Table 1). A 
plasma exchange of 1.5 times the calculated plasma volume 
will deplete an intravascular substance by about two-
thirds. Exchanging a larger volume gives small addi-
tional yield. An assumption implicit in these con-
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Table 1. Relationship of Plasma Exchange Volume and 
Removal of Intravascular Substance 
Plasma Volume ::: 40 mL/kg 
No. Plasma Volume Percent 
Volumes (mL) Remaining 
0.5 1,400 65 
1.0 2,800 45 
1.5 4,200 35 
2.0 5,600 30 
From: Linker, C.: Plasmapheresis in Clinical Medicine. 
West Jrn Med 1983; 138:60-69. 
elusions is, as Berkman (131) reports, that no net shift 
occurs between the extravascular and intravascular space 
and that there is no further major synthesis of the fac-
tor being removed. 
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Taft (132) reports the most efficient pheresis proce-
dures are those involving cells of density significantly 
less than that of the predominant erythrocyte population. 
In plasma exchange, the extent of depletion of components 
not present in the replacement fluid depends on the rate 
of replacement, their extravascular concentration and syn-
thetic rate. Since apheresis procedures have access only 
to the intravascular compartment, the success of the 
treatment is largely related to volume of blood processed 
and the rapidity with which clearance occurs. 
As reported by Linker (130), plasmapheresis is a 
field of medicine that has been created by the availabili-
ty of a new technology. There are currently three dif-
ferent pieces of equipment designed for on-line cell 
and/or plasma separation, procurement, or removal. Sil-
vergleid (133) lists these as Haemonetics' Model 30 (Hae-
monetics Corp., Braintree, Mass.), IBM's 2997 (IBM Bi-
omedical Systems, Princeton, New Jersey), and Fenwal's CS 
3000 (Fenwal Laboratories, Deerfield, Illinois). All 
three are designed to create an interface between dif-
ferent constituents of the blood based on the differen-
tial effect of centrifugation, and to effect collection 
and/or removal of the desired component based on har-
vesting at that interface. The Haemonetics Model 30 re-
lies on a disposable bowl in which separation occurs; is 
an operator-dependent function; and is a discontinuous, 
or intermittent procedure. The procedure can be per-
formed through one venipuncture. Both the IBM 2997 and 
the Fenwal CS 3000 are based on continuous flow. In ad-
dition, the IBM is partially, and the Fenwal almost com-
pletely, automated and therefore less dependent upon 
operator judgment. Two venipunctures are necessary to 
perform the continuous exchange. 
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Despite the design of the unit, the potential for 
operator error exists. This is a relatively new procedure 
often performed by inexperienced personnel. Werynski et 
ala (134) report that setting the plasma flow rate above a 
certain critical value can result in hemolysis. The 
physical feature of hemoconcentration is a significant 
variable in this excessive value. Wiltbank et ala (135) 
and Malchesky et ala (136) in an attempt to overcome 
plasmapheresis based on centrifugation and thereby 
limited in efficiency by the sedimentation rate blood 
cells, developed a new approach using cross-flow filtra-
tion. By using a microporous membrane, having pore 
dimensions between 0.4 and 0.8 um and flowing the blood 
across a laminar field parallel to the membrane while 
maintaining a positive transmembrane pressure, plasma 
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filtration without red blood cell damage and/or membrane 
clogging occurred. The problem with the system was the 
time necessary to accomplish even a small plasmapheresis; 
it was found not to be of value with large-volume ex-
changes. Filters with specific macromolecular weight 
cut-offs are also being evaluated. Kayashima et ala 
(137) conducted an evaluation of three kinds of hollow 
fiber type membrane filters used as a second stage mem-
brane filtration unit in an effort to return essential 
substances. They found they could, in fact, return sub-
stances such as albumin to the patient. This preliminary 
work demonstrates the possible clinical application of 
selective removal filters and the need for further re-
search. This area of research, referred to as cascade 
filtration, is being actively pursued. Gurland (138) re-
ports a tremendous decline in the membrane surface area 
of plasma filters. Early models had a membrane surface 
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area of 6,500 cm i the smallest currently available com-
mercial devices (Dideco, Travenol and Cobe) require only 
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about 1,500 cm. The clinical significance is related to 
the amount of blood in the filter at any given time and 
to cost. 
The increasing availability of cell separators has 
made it possible to investigate the use of large-volume 
plasma exchange to modify diseases associated with high 
levels of circulating antibody or antigen-antibody com-
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plexes. Jones (139) reports a large variety of sizes of 
immune complexes and that some complexes may be more 
harmful than others. At the present time, the state of the 
art is that molecular weight alone determines upon which 
side of the membrane filter a cell will locate. Feng 
(140) reports that the American Red Cross currently lists 
61 disease states treatable by therapeutic plasmapheresis, 
and the list is still expanding. The majority of reports 
about the use of plasmapheresis are highly anecdotal, and 
there is a paucity of controlled trials. Kleit (141) in 
an editorial, states that randomized controlled studies in 
apheresis will be expensive, complicated, time consuming, 
and possibly lethal to some patients. Some of the issues 
to be resolved, as reported by Wenz and Barland (142), in-
clude patient selection; frequency, intensity, and dura-
tion of the procedure; amount and type of replacement 
fluids; serological monitoring, and outcome criteria for 
continued use. 
The use of plasmapheresis in clinical practice in-
cludes its use by Wood et ale (143) for two patients with 
refractory myasthenia gravis, one rhesus-sensitized woman, 
one procedure to diminish the anti-A titre in a patient 
requiring bone marrow transplant, and one procedure for S 
concentration reduction of a sickle cell disease patient. 
This group reported improvement and no complications asso-
ciated with plasma exchange. Valbonesi et ale (144) re-
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port that patients with high titers of circulating immune 
complexes are most likely to benefit from plasmapheresis. 
seventeen patients with immune complexes were plasma-
pheresedi prepheresis, 14 of the patients had high complex 
levels while three patients had no evidence of circulating 
immune complex. The 14 high circulating level patients 
showed clinical and immunochemical improvement postphere-
sis while the other three patients showed no change. 
Blacklock et ale (145) have treated 26 patients with Good-
pasture's Syndrome or dysproteinemias and concluded that 
the clinical improvement warranted the exchanges. Wenz 
and Rubinstein (146) treated one patient with acquired 
agammaglobulinemia and produced a clinical remission of 
five month's duration. Robinson and Tovey (147) treated 14 
high-risk cases of Rh alloimmunized women with intensive 
plasma exchange throughout their pregnancies in weekly 
procedures. Successful outcome was achieved in nine of 
the 12 cases. Ginder et ale (148) used plasma exchange 
three times in a patient with mixed cryoglobulinemia with 
some success until the patient's death. Hepatic failure 
has been treated by Fujita et al. (149), Kayashima et al. 
(150), and Smith et al. (151) with mixed success in small 
groups of patients. Evans et al. (152) discuss a case 
study of the successful use of plasmapheresis in a patient 
with systemic lupus erythematosus. There are a variety of 
other reports but, as previously stated, the data is from 
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much too small a sample to be the basis for conclusions. 
Silvergleid (133) reports five general categories, based 
on the mechanics of the disease, which might theoretically 
benefit from plasmapheresis. These are diseases asso-
ciated with a) abnormal (or excess) plasma proteins, 
toxins, or metabolic products; b) autoantibodies; c) al-
10antibodies; d) immune complexes; and e) miscellaneous 
disorders. 
Complications of plasmapheresis have been reported 
to occur infrequently. Linker (130) reports that fi-
brinogen, the third component of complement (C3), and im-
mune complexes are depleted 75 to 85% after a 1.5 volume 
exchange. Immunoglobulins are removed with a 65% deple-
tion. Electrolytes, uric acid, and selected proteins 
such as factor VIII are removed very inefficiently. Ery-
throcyte loss is predicted to be in the range of 30 mL 
per procedure. The platelet count will often be slightly 
reduced, but thrombocytopenia to levels less than 50,000 
ul occurs in about 10% of cases (130). Complications may 
also attend the infusion of large amounts of plasma. 
Silvergleid (133) identifies the possibilities of citrate 
toxicity, cardiac arrhythmias, hepatitis, anaphylaxis, 
and hemolysis. Also mentioned is the fact that approxi-
mately 24 deaths directly attributable to plasma exchange 
have been reported. The source is a personal communica-
tion and no further information is provided. Huestio 
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(153) in an editorial, reports 42 deaths that seem to 
have been associated with hemapheresis. Sixteen of these 
deaths occurred in the United States, 20 occurred in 
France, three occurred in Canada, and three in other 
countries. The replacement fluid was either albumin (6 
cases), fresh frozen plasma (23 cases), or both (7 
cases). The major causes of death are cardiac, respira-
tory, or anaphylactic. 
McLeod (154) discusses the immunologic factors in 
blood transfusions as consisting of two distinct etiolo-
gies when plasma is the solution being infused. First, 
the plasma can serve as a source of antibodies that may 
react with cells in the recipient's bloodstream (intravas-
cular hemolysis). In addition, plasma proteins may serve 
as a source of antigen thus leading to the potential for 
antigen-antibody reactions in subsequent transfusions. 
Hepatitis is also a risk factor associated with transfu-
sion. 
The anticoagulant used in the tubing of most plasma-
pheresis machines is an acid citrate dextrose (ACD) solu-
tion, a solution known to bind serum calcium. Watson et 
ale (155) and Morse et ale (156) have reported decreased 
ionized calcium during therapeutic plasma exchange. Hypo-
calcemia may lead to a decrease in the strength of cardiac 
contractions. The problem is manifested on the electro-
cardiogram as a lengthening of the QT interval and is as-
sociated with fibrillation. 
Hypokalemia has also been reported in association 
with plasma exchange. This problem is mani sted on the 
electrocardiogram as a prolonged PR interval, low ampli-
tude T-waves, premature ventricular contractions, and 
fibrillation. Hypotension associated with hypovolemia 
can occur if blood is removed from the patient too 
rapidly. 
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Access sites and the tubing itself are also potential 
sources of complications. The tubing itself may become a 
source of free air leading to air embolus if there are 
leaks in the system. In addition, severe uncontrolled 
hemorrhage occurs if the access tubing becomes disconnec-
ted from the plasmapheresis machine tubing. Sterile 
technique is practiced at all interfaces between the pa-
tient and machine to prevent bacterial contamination. 
Crismon (157) reports that plasmapheresis is a new 
type of therapy that holds promise for the treatment of an 
array of critical disorders. Considered experimental un-
til recently, the procedure's impact upon critical care 
nursing is growing, as nurses become involved in the 
treatment of plasmapheresis patients. The critical care 
nurse must be prepared to continuously monitor the pa-
tient's status during the procedure. Crismon states that 
the critical care nurse normally monitors the patient's 
condition and carries out nursing duties while another 
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person (a nurse or technician) who has received special 
training in operation of the pheresis equipment performs 
the treatment. Cona(158) reports that pheresis operators 
are usually trained at the facility where they will be 
working. The training is generally supplied by the 
company from which the instrument is purchased. 
Plasma Exchange in Burn Patients 
There is currently only one burn center performing 
plasma exchange in burn patients. Clinical evaluation of 
plasma exchange was begun at the Intermountain Burn 
Center, Salt Lake City, Utah, in 1979. Initial results of 
this experience were published by Warden (85) and Warden et 
al. (159) in 1983. Plasma exchange in burn patients was 
performed on a group of patients when they failed to re-
suscitate from burn shock using conventional therapy. Ir-
reversible burn shock results from failure of fluid resus-
citation and is almost invariably fatal. Because of the 
implied role of circulating serum factors in the genera-
tion of burn shock, the use of plasma exchange was 
evaluated retrospectively in patients with major thermal 
injuries who had failed to respond to conventional therapy 
and had undergone plasma exchange. 
Twenty-two patients with a mean burn size of 47.9% 
TBSA and a mean age of 22.7 years underwent exchange for 
ongoing burn shock after standard fluid resuscitation 
failed. Fourteen of these patients were adults and under-
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went plasma exchange; eight of the patients were children 
who underwent exchange transfusion Qfwhole blood and 
platelets. A therapeutic response was documented in 
95.4% of the patients. The improvement was characterized 
by a sharp decrease in fluid requirements from a mean of 
260% above the predicted hourly volume to within calcu-
lated requirements by 2.3 hours following the exchange. 
Markedly improved urine output and resolution of lactic 
acidosis were also demonstrated. No major complications 
occurred. 
The results of this study demonstrated that an al-
tered internal environment exists following thermal in-
jury. Whether the mechanism of action of plasma exchange 
involves the removal of circulating toxic factors, the re-
plenishment of specific deficiencies, or a combination of 
the two remains to be determined. Conclusions from this 
study were: a) plasma exchange can be performed safely in 
critically injured burned patients; b) plasma exchange ar-
rests ongoing burn shock through an as yet undefined 
mechanism resulting in a dramatic reversal of fluid re-
quirements, a brisk diuresis, a resolution of lactic aci-
dosis, and a restoration of capillary integrity; and c) 
plasma exchange facilitates resuscitation from burn shock 
in a select group of patients who do not respond to con-
ventional volume therapy. 
Although this report is preliminary and involves a 
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heterogeneous patient population without adequate con-
trols, the return toward normal of various clinical para-
meters in nearly all of these patients was encouraging. 
Plasma exchange in order to provide a potential alterna-
tive in burn shock resuscitation by returning the altered 
internal milieu toward normal was indicated. The nurse 
administering the fluid volume would need to determine the 
effect of plasma exchange on the fluid requirements. 
Thus, a reseach question arises: Does plasma exchange 
performed during burn shock alter the predicted resuscita-
tion fluid requirements a burn nurse may expect to deliver 
to a patient in burn shock? 
Summary 
Burn shock appears to consist of both a hypovolemic 
and a cellular component. Hypovolemic shock results from 
an increase in capillary permeability which begins with 
the onset of thermal injury and persists for approximately 
24 hours postburn, even when supportive therapy in the 
form of fluid resuscitation is provided. Investigations 
have documented the release of many mediators of the in-
flammatory response which may play roles in the cardiovas-
cular response to burns. These include vasoactive amines, 
metabolic hormones, products of arachidonic acid metabo-
lism, kinins, polypeptides, endotoxin, fibronectin, and 
others. Evidence suggests that with onset of the burn 
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wound, cellular metabolism is also disrupted. This re-
sults in altered membrane permeability and loss of normal 
electrolyte homeostasis associated with the flux of sodium 
and water into the cells and the loss of intracellular po-
tassium. This cellular effect may be the pathophysiologic 
process responsible for the genesis of burn shock. These 
circulating factors altering fluid dynamics not only ef-
fect the capillary permeability but also lead to decreased 
vascular colloid osmotic pressure and a deranged capillary 
hydrostatic pressure. The result is an excess of fluid in 
the interstitial space in the form of edema and a de-
creased circulating volume. Also, the many circulating 
factors present in burn serum may play a reciprocal 
role in the generation of the cellular abnormalities ob-
served. 
Preliminary investigations into plasma exchange in 
the treatment of burn shock inpatients who have not 
responded to conventional management report marked im-
provement in several clinical settings, including refrac-
tory resuscitation failure, acute respiratory distress, 
myoglobinuria associated with major electrical injury, 
and the syndrome of metabolic exhaustion or presepsis. 
In treating patients suffering resuscitation failure, 
plasma exchange has demonstrated an immediate decrease in 
fluid requirements, resolution of lactic acidosis, and a 
return to a normal resuscitation schedule. 
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The current paradigm of supportive burn therapy as-
sumes that optimal care consists of the administration of 
fluids at the same rate and in the same volume and compo-
sition in which they are lost. This paradigm is outdated 
in view of advances in knowledge and state of the art 
technology available. A therapeutic paradigm imvolves 
restoring cardiovascular and physiological integrity as 
early as possible postburn. The combination of plasma 
exchange with supportive therapy is the treatment para-
digm supporting this study. 
CHAPTER III 
DESIGN AND METHODOLOGY 
This chapter will present the design and methods of 
procedure. 
Design 
The design chosen to answer the research questions 
of this study was experimental with random assignment of 
14 consenting burn subjects to one of two treatment 
groups. One group of subjects received standard resusci-
tation according to the Parkland formula. A second group 
of subjects received standard resuscitation in con-




All patients between 15 and 60 years of age admitted 
to the Intermountain Burn Center and suffering acute 
burns of greater than or equal to 40% TBSA were con-
sidered for inclusion as subjects in the study. Because 
of the difficulty in estimating burn size in outlying 
hospitals, no patient was admitted to the study as a sub-
ject prior to initial evaluation in the burn center it-
self. Estimation of burn size was carried out using the 
Lund and Browder Chart (Appendix A) and included esti-
mates of both partial- and full-thickness burns. To be 
included in the study, subjects had to have burn wound 
involvement of 40% or greater TBSA injury. 
Human Subjects 
Human subjects· approval was obtained from the Hu-
man Subjects Committee of the University of Utah Medical 
Center prior to data collection. Upon arrival at the 
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burn center, the extent of the wound was determined and 
standard burn care initiated. After determining that the 
patient had a burn injury of 40% TBSA or greater, the pa-
tient and family were interviewed by a burn physician for con-
sent to participate in the study. Informed consent from 
the patient and next-of-kin was necessary for the patient 
to be included in the study. Consent was obtained using 
a specially written consent form which had been approved 
by the Human Use Committee of the University of Utah 
Medical Center. The consent form included descriptions 
of both the invasive monitoring and of the plasma ex-
change procedure to be performed. No claims of docu-
mented efficacy for plasma exchange therapy were made. 
Risks were explained verbally and in writing. Patient 
participation was voluntary with the option to withdraw 
from and/or ask questions about the study at any time. 
Anonymity was maintained. In addition, the subjects were 
told that if they were entered into the control group and 
subsequently showed evidence of resuscitation failure, 
they would have the option of undergoing plasma exchange 
as a therapeutic procedure. 
Because this study involved legally minor subjects, 
the consent for entry into the study was signed by the 
legal next-of-kin when the patient's age was 15 to 18 
years. 
Complications and Risks 
of the Study 
The risks associated with participation in the study 
were essentially threefold: complications associated 
with placement of catheter lines, complications asso-
ciated with the plasma exchange procedure, and complica-
tions associated with the drawing of blood samples. 
The complications associated with placement of the 
two additional lines directly related to the study were 
identified as a risk. The Swan-Ganz catheter was placed 
for monitoring of cardiac parameters and obtaining mixed 
venous blood gas samples; the additional l4-gauge venous 
line was placed for the plasma exchange procedure access. 
Both of these lines were placed under the direct supervi-
sion of one of the physician-directors of the Burn Cen-
ter. Potential risks from Swan-Ganz catheter placement 
in any patient include pneumothorax, hemothorax, hydro-
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thorax, arterial puncture, cardiac tamponade, and ar-
rhythmias secondary to placement of the catheter. All of 
these complications are exceedingly rare. In order to 
minimize their occurrence further, an effort was made to 
place all catheters through an internal jugular rather 
than the subclavian approach. The internal jugular ap-
proach was attempted because of the lower risk of pneumo-
thorax and the greater ease in treating an arterial 
puncture. In order to minimize the possibility of ar-
rhythmia, all subjects had continuous ECG monitoring 
during placement of the Swan-Ganz catheter. Lidocaine 
and cardiopulmonary resuscitation equipment were im-
mediately available. Placement of the 14-gauge line for 
plasma exchange was performed in a femoral vein which has 
few complications. 
Potential complications associated with the plasma 
exchange procedure were also identified as risks. The 
procedure carries with it the associated risks of hypo-
tension due to excessive volume withdrawal, air embolism 
from operator error, and hepatitis from the volume of 
fresh frozen plasma infused. Complications related to 
the withdrawal of excessive volume were controlled by the 
continuous flow technique employed. Fluid balance was 
maintained at or near zero at all times during the proce-
dure. The risk of air embolus was decreased by using on-
ly fully-trained and experienced pheresis technicians who 
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were additionally alerted by both audible and visible 
alarms built into the machine to signal an air-in-line 
warning. The infusion of large quantities of fresh fro-
zen plasma carried the theoretical risk of transfusion 
reaction, although this was less than if whole blood had 
been used. In addition, the possibility of transmission 
of viral hepatitis existed. 
Complications associated with the withdrawal of mul-
tiple blood samples were also considered. Because the 
subjects had an indwelling arterial line throughout the 
study period, there were no complications associated with 
the performance of venipuncture for the withdrawal of 
blood samples. The total volume of blood to be withdrawn 
during the course of the experiment was calculated to be 
approximately 350 mL (Appendix B). Existing protocols in 
the Burn Center required a similar battery of blood tests 
to be obtained on all patients with major burns every six 
hours; thus, the 350 mL represented an increase of ap-
proximately 33% in the quantity of blood to be drawn from 
study patients. The difference was between 120 and 150 
mL in the 48 hour study period. 
Invasive Monitoring 
Upon admission to the burn center, all patients with 
burns of 40% TBSA or greater routinely undergo placement 
of the following invasive lines: 
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1. Nasogastric tube: Placement is via the naris 
whenever possible; oral placement is an option. A 2-part 
tube of appropriate size is placed, secured, documented to 
be in physiologic position by radiographic exam, and 
connected to low (20 to 40 mm Hg) constant suction. 
2. Foley bladder catheter: Placement of a catheter 
of the appropriate size is accomplished using sterile 
technique. When in position, as verified by urine re-
turn, the cathether is conneced to a down-drain bag with 
a built-in urimeter. 
3. Large-bore intravenous lines for fluid resusci-
tation: At least one l4-gauge catheter is placed into 
the internal jugular, subclavian or femoral vein using 
sterile technique. The site selected for line placement 
is based upon the location of the burn wound and the mo-
bility and preference of the patient. Lines are sutured 
in place and position verified by radiographic exam. 
4. Arterial line: An arterial line is placed into 
either the radial or femoral artery. A 20-gauge catheter 
is routinely used for the radial artery and an IS-gauge 
line for the femoral artery. The line is then attached 
to a pressure transducer with flush system connected to a 
patient monitor (Mennen Model 4S0, Clarence, NY) and su-
tured into place. 
In addition to the above lines, subjects in this 
study underwent the placement of a Swan-Ganz thermodilu-
tion catheter (Model 93A-131-7F, Edwards, Inc., Santa 
Ana, Ca.). The catheter was threaded through a hollow 
plastic catheter introducer (Cordis, Inc., Miami, Fla.) 
into either the internal jugular, subclavian, or femoral 
vein. The balloon-tipped Swan-Ganz catheter is equipped 
with pulmonary artery and central venous ports and an 
electronic thermister. pulmonaiy artery pressure is 
monitored by attachment of the catheter's distal port to 
a pressure transducer connected to a patient monitor 
equipped with oscilloscopic display of pressure tracings, 
digital readout of pressures, and a strip recorder. 
While continuously monitoring pressures, the catheter is 
flow-directed into the proximal pulmonary artery and mea-
surements of wedge pressure obtained. Appendix C lists 
normal values and formulas used for the calculation of 
cardiopulmonary profiles. During catheter placement, the 
electrocardiogram (ECG) is monitored continuously for the 
occurrence of arrhythmias; cardiopulmonary resuscitation 
equipment and personnel certified in cardiopulmonary re-
suscitation techniques are available at the bedside. 
Once in position in the pulmonary artery, the catheter is 
sutured into position and placement confirmed by a porta-
ble chest radiograph. 
Resuscitation 
All subjects underwent initial resuscitation accor-
ding to the Parkland formula. This formula called for 
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the intravenous infusion of lactated Ringer's solution 
(Appendix D) at a rate of 4 mL/kg/% TBSA burn. Half of 
the calculated volume was given over the initial eight 
hours following thermal injury and the remainder over the 
ensuing 16 hours. Standard guidelines for assessing the 
success of fluid resuscitation were used with the primary 
criteria being urine output. Subjects underwent the in-
sertion of a Foley bladder catheter as soon as was clini-
cally feasible; hourly urine output determinations were 
made thereafter for a 48 hour period. Fluid volumes were 
adjusted to maintain urine output at a range of 30-50 mL 
per hour. Subjects whose urine output was less than this 
value were given additional fluid in volumes sufficient 
to improve urine output; subjects whose urine output was 
in excess of this amount underwent appropriate decreases 
in fluid infusion. 
Patients transported to the burn center from long 
distances had their fluid resuscitation begun prior to 
transport. In no case was fluid resuscitation withheld 
or adjustments in fluid resuscitation made according to 
the planned entry of the patient into the study. 
Documentation of Inhalation Injury 
All subjects suffering potential exposure to toxic 
products of combustion were evaluated for inhalation in-
jury. The evaluation was based on clinical findings but, 
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in all cases, objective documentation was by xenon 
perfusion scan. In addition, subjects who underwent en-
dotracheal intubation had fiberoptic bronchoscopy per-
formed. Diagnosis of inhalation injury was based upon 
the presence of two of the following three criteria: 
1. Clinical findings consisting of oropharyngeal 
burns; carbonaceous sputum; respiratory distress or 
wheezing; facial burns, singed vibrissae and facial hair; 
or upper airway edema. 
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2. The presence of a positive xenon scan con-
sisting of retention of isotope beyond 90 seconds in seg-
mental areas of the lung or diffuse retention for longer 
than 120 seconds. 
3. Bronchoscopic evidence of inhalation injury con-
sisting of tracheal or broncheolar edema, erythema, des-
quamation, or carbonaceous deposits. 
In addition, arterial blood gas analysis was per-
formed on admission to the burn center for the purpose of 
assessing respiratory parameters and documenting carboxy-
hemoglobin content. An admission chest radiograph was 
also obtained on all subjects. 
Randomization of Subjects 
to plasma Exchange 
The population of burn patients admitted to the burn 
center was considered to be a true sample of all burn 
patients from a large geographical area based on two 
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factors. The first factor is that the burn center has a 
policy to accept all burn patients for admission. The 
second factor is that the burn center is the regional re-
ferral center for all hospitals in the intermountain 
area. Thus, since essentially all hospitalized patients 
with major burns are transferred to this burn center and, 
since the burn center refuses no admissions, a basic 
assumption is that the criteria for achieving representa-
tive sampling of burn patients appeared to be met. 
Random assignment of subjects into the treatment 
group or control group was accomplished using a table of 
random numbers (Appendix E). Prior to the beginning of 
the study, 96 numbers were sequentially paired. Each 
pair was then numbered sequentially one through 48. 
Using the pair number, reference was made to a standard 
table of random numbers with the first number of each 
pair being assigned either to the treatment or control 
group. The second number of each pair was then desig-
nated to the other group. Based on these assignments, a 
series of 96 envelopes were numbered sequentially; a card 
designating that individual's group assignment was placed 
inside; and the envelope was sealed. A box containing 
all 96 envelopes in proper numerical sequence was placed 
at the nurses' station. On admission to the burn center, 
patients who qualified for the study were approached by a 
physician for consent. After obtaining consent, the en-
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velope in the front of the box was opened by a staff mem-
ber to learn to which group the subject was assigned. 
The rationale for pairing the subjects was to offset 
both the seasonal nature of burn admissions and the not 
infrequent occurrence of multiple admissions from a 
single fire or other catastrophe. If random assignment 
of 96 individual numbers had been performed, it would 
have been possible for many numbers in series to be as-
signed to the same group. If this occurred during the 
winter months when patients have a higher incidence of 
inhalation injury due to burn injuries sustained in a 
house fire, a bias regarding the plasma exchange treat-
ment could have resulted. 
Similarly, if a number of patients injured in a 
single accident were admitted simultaneously, the pairing 
system assured that they were evenly and randomly as-
signed to the two treatment groups. Finally, since the 
pairing system assured that both the control and treat-
ment groups contained an equal number of subjects, the 
performance of periodic review of results facilitated 
analysis of the data. Placing individual assignments in 
sealed envelopes sequentially numbered assured that the 
order of treatment assignment was not subject to bias. 
Arrangement for assignment of 96 subjects was made to as-
sure that the number of studies necessary to reach sta-
tistical significance would not exceed the number ini-
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tially randomly assigned. Because of limited knowledge 
regarding the effect of plasma exchange on burn patients, 
there was no way to predict the number of trials neces-
sary to reach a conclusion prior to beginning the study. 
Continual review of results was built in to the design so 
that the endpoint of the study was statistical signifi-
cance. 
Performance of Plasma Exchange 
Subjects randomized to undergo plasma exchange had 
the procedure performed as soon as was clinically 
feasible. That is, all access lines were immediately 
placed and plasma obtained in readiness for the procedure 
to begin as soon as consent was obtained. Patients who 
were not admitted to the burn center in time to begin 
plasma exchange by the fifteenth postburn hour were not 
considered for entry into the study protocol. 
Plasma exchange was performed using an IBM Model 
2997 continuous blood cell separator (IBM Systems, Endi-
cott, N.Y.). The performance of the procedure was under 
the technical direction of the medical director of the 
University of Utah Medical Center pheresis center and 
blood bank. The procedure was performed by plasmaphere-
sis technicians at the subject's bedside in the burn cen-
ter. 
The IBM 2997 separates whole blood into its major 
components with the advantage over discontinuous cell se-
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para tors of requiring virtually no extraneous volume from 
the patient to prime the machine. Blood flow to and from 
the patient is controlled by variable speed roller pumps. 
A centrifuge separates the blood into its components 
based upon their specific gravities. Strategically 
placed pipettes within the machine collect the various 
components of the blood as it is separated in the centri-
fuge. Anticoagulant is injected into the blood as it is 
removed, in a whole blood-to-anticoagulant ratio of 10:1. 
Acid citrate dextrose (ACD) formula A (Fenwal Labs., 
Deerfield, Ill.) is employed as an anticoagulant. Blood 
is withdrawan through one of the large intravenous cathe-
ters and entered into the blood separation channel 
(Ethox, Inc., Buffalo, N.Y.) in place in the machine. As 
blood is spun, the plasma component is removed and col-
lected in storage bags for research use. Erythrocytes, 
platelets, and white cells are returned to the patient 
through a second large bore intravenous line. Simul-
taneously, the volume of plasma removed from the patient 
is replaced mL for mL with type-specific fresh frozen 
plasma from the University Hospital Blood Bank. The 
fresh frozen plasma used is prepared from whole donor 
blood in which the plasma is separated by centrifugation 
and frozen at -30 degrees C within six hours of collec-
tion. Fresh frozen plasma has a dating period of 12 
months after which time it is deficient in Factor VIII 
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and must be discarded. The fresh frozen plasma is 
quickly thawed immediately prior to use to prevent loss 
of labile coagulation factors. 
Subjects undergoing plasma exchange had a calculated 
volume of exchange equal to one and one-half times their 
calculated blood volume. This was based on the following 
calculation (160): For males, blood volume equals 7% of 
the body weight in kilogramsj for females, blood volume 
equals 8% of body weight. The plasma exchange procedure 
was regulated so as to be completed in the shortest pos-
sible time. Because of mechanical limitations, the pro-
cedure takes a minimum of two to five hours. Regulation 
also kept the patient's balance of exchange fluid ap-
proximately equal to zero thus preventing over- or under-
hydration during the course of the exchange procedure. 
Continuous monitoring of blood pressure and other vital 
signs was performed throughout the procedure. Parkland 
fluid resuscitation continued throughout the period of 
plasma exchange and was modified according to the stan-
dard parameter of urine output. 
Completion of Resuscitation 
Following resuscitation from burn shock, patients 
with major burns have increased requirements for mainte-
nance fluid. All subjects in this study had hourly urine 
output determinations, with fluid requirements modified 
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as needed. When a subject was able to maintain a urine 
output of 30 to 50 mL per hour for two hours with the 
volume of fluid infusion equal to calculated maintenance, 
fluid resuscitation ws considered complete and burn shock 
reversed. 
Maintenance fluid requirements in burn patients are 
predicted by using two standard calculations. The first 
calculates evaporative water losses from the burn wound 
(161) : 
2 
(25 + % TBSA burn) (BSA m ) = evaporative loss in 
mL/hour. 
Formula components: 
25 = constant as described in reference by Warden et 
ale (161). 
% TBSA burn = percent total body surface area burn as 
described by Lund and Browder (Appendix A). 
2 
BSA m = body surface area as described by 
Dubois (162). This formula, the "Height - Weight Formula," 
estimates the surface area of subjects when their height 
and weight are known and is expressed as: 
0.425 0.725 
BSA = W X H x c 
with BSA being surface area in square centimeters, W 
the weight in kilograms, H the height in centimeters, and 
C the constant, 71.84. A chart has been plotted from 
this formula (Appendix F). 
The second formula calculates other maintenance fluid 
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requirements (urine output, stool, respiratory losses) and 
is expressed as: 
2 
(1500 mL) (BSA m ) = Maintenance requirements in mL 
per 24 hours 
or 
2 
(62.5 mL) (BSA m ) = Maintenance requirements in mL 
per hour 
Total maintenance fluids for burn patients are equal 
to the addition of the two formulas or: 
2 
(25 + % TBSA burned + 62.5) (BSA m ) = mL per hour. 
Thus, when a subject sustained an adequate urine 
output of 30 to 50 mL per hour for two consecutive hours 
on the predicted amount of infused maintenance fluid, re-
suscitation criteria were met. In addition to urine out-
put, completion of resuscitation was monitored by evalua-
tion of the subject's clinical status using other parame-
ters including vital signs and serum laboratory reports. 
upon completion of resuscitation, all subjects received 
an infusion of type-specific fresh frozen plasma equal to 
20% of their calculated blood volume. All subjects were 
then given standard maintenance therapy consisting of 5% 
dextrose in 0.2% normal saline (D5.2NS) at a rate calcu-
lated to equal maintenance needs. 
Data Collection 
Subjects entered into the study had a number of 
blood chemistry determinations made at specified times 
throughout the 48 hour course of the study. Blood sam-
ples were withdrawn by burn center staff through the ar-
terial line, utilizing a three-way stopcock and sterile 
technique. The line was flushed with normal saline fol-
lowing each withdrawal. Blood was aspirated into sterile 
plastic syringes and transferred to the appropriate tube 
(Vacutainer Systems, Rutherford, N.J.) for transportation 
to the pathology laboratory at University Hospital. 
There the samples underwent standard automated techniques 
employed for the determination of specific values. Ap-
pendix G presents normal ranges of laboratory values. 
For determination of arterial and mixed venous gas con-
tents, blood was drawn into sterile preheparinized 
plastic syringes (Concort Labs, Keene, N.H.), placed in 
ice, and transported immediately to the pulmonary labora-
tory at University Hospital. Appendix C presents normal 
values for blood gas determinations. 
Serum determinations were made serially on each sub-
ject admitted to the study. Appendix H lists the vari-
ables and the intervals postburn that samples were ob-
tained. 
Physiologic variables measured serially by burn 
center staff included: 
1. Vital signs: Heart rate, respiratory rate, core 
body temperature utilizing the Swan-Ganz catheter connec-
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ted to the Edwards cardiac output instrument, and sys-
temic blood pressure using the arterial line transducer 
connected to the Mennen monitoring instrument. 
2. Swan-Ganz measurements: Pulmonary artery mean 
and systolic/diastolic pressures; pulmonary capillary 
wedge pressures; central venous pressures; and cardiac 
output determinations. Determinations of cardiac output 
were made by the technique of thermodilution using ste-
rile D5W maintained in ice at a temperature of 0 degrees 
C. A 10 mL aliquot of iced D5W was injected into the 
proximal port of the Swan-Ganz catheter following verifi-
cation of its position by pressure tracing and portable 
chest radiograph. Measurement of blood temperature at 
the distal pulmonary artery port was made by the thermis-
tor incorporated into the catheter. Calculation was made 
using the Edwards Model 9520 cardiac output computer. 
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All determinations were made in triplicate within one min-
ute intervals and the mean of the three values used as 
the recorded value. The normal values for these 
parameters are presented in Appendix C. 
3. Intake: All infusions were measured and recorded 
according to content, amount, and route administered. 
4. Output: All output, including urine, nasogastric 
tube drainage, stools, emesis and estimated blood loss 
were measured and recorded. 
5. Ventilatory status including settings of venti-
lator and timing of changes made in settings. These pa-
rameters include fraction of inspired oxygen (Fi02), ti-
dal volume, mode of therapy, ventilator rate, and posi-
tive and expiratory pressure (PEEP) setting. 
Cardiac profiles were calculated by computer techni-
cians using the Telemed Cardiopulmonary System (Tenet 
Company, Salt Lake City, Utah) to determine arterial ve-
nous oxygen difference, oxygen consumption, oxygen 
availability, oxygen extraction, pulmonary vascular re-
sistance index, systemic vascular resistance index, car-
diac index, stroke index, and percent of shunt. The for-
mulas used to calculate these values are presented in Ap-
pendix C. 
Data collected on each subject also included age; 
sex; percent TBSA burn with division into partial- and 
full-thickness injury; etiology of injury; time postburn 
intravenous resuscitation was begun; time postburn admit-
ted to burn center; presence of inhalation injury; con-
commitant injury; preexisting disease and current med-
ications; weight; height; body surface area; calculated 
fluid and sodium requirements according to Parkland for-
mula and maintenance formula; actual fluid and sodium re-
quirements; amount of intake and output; survival; and, 
in the treatment group, plasma exchange data. 
The nursing staff of the burn center carried the 
primary responsibility for adherence to the research pro-
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tocol. The member of the burn center staff assigned to 
deliver care to the patient was responsible for incor-
porating the research protocol activities into the sub-
ject's burn care. Assignment of staff is the responsibi-
lity of the charge nurse on each shift. The nursing 
staff works 12-hour shifts so that at least four dif-
ferent nursing shifts were responsible for the care of 
the subject during the 48 hour study period. All staff 
caring for critically ill patients on admission are ex-
perienced burn center personnel. In addition, the two 
medical directors, the clinical specialist, and the head 
nurse of the burn center were available as a resource at 
all times during the study period. To clarify the speci-
fic tasks associated with the study, a list of the 
nurse's hourly responsibility during the plasma exchange 
research study was developed (Appendix I). This list was 
included in the envelopes containing the assignment to 
group card so that it was ilnmediately available to the 
nurse whose patient entered into the protocol. 
Termination of the study 
All study parameters were followed for a total of 48 
hours from the time of burn injury. At that time, the 
Swan-Ganz catheter was removed if the subject was suffi-
ciently stable to warrant discontinuing this method of 
monitoring. The arterial line was also removed at that 
time if clinical circumstances permitted. 
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The participation in the study by an individual was 
terminated at any time during the course of the study 
under the following circumstances: 
1. If the subject expressed a desire to withdraw 
participation in the study. 
2. If the subject's family expressed a desire for 
the subject to be withdrawn from the study. 
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3. If significant complications arose as a result of 
procedures incorporated into the study which were not 
considered routine procedures; i.e., Swan-Ganz catheter 
placement, plasma exchange procedure. 
4. If plasma exchange could not be started by 15 
hours postburn. 
If a study subject died before the 48 hour postburn 
period had elapsed, that subject remained in the study for 
the purpose of analysis of all data gathered up to the 
time of death. 
other Burn Therapy 
Entrance into and participation in this study did 
not, in any way, compromise other aspects of burn care. 
All standard protocols used in the burn center were con-
tinued in subjects entered into the study. These in-
cluded aggressive cimetadine and antacid prophylaxis to 
guard against the development of gastric stress erosions; 
aggressive nutritional support including vitamin therapy; 
early excision and autografting of all full- and deep 
partial-thickness burns; and early, vigorous physical 
therapy. 
Resuscitation Failure 
Subjects entered into the plasma exchange protocol 
who were randomized to be controls continued to be at 
risk for developing resuscitation failure. Resuscitation 
failure was defined as a subject who, at 18 hours 
postburn, still required in excess of twice the calcu-
lated volume of resuscitation fluid to maintain urine 
output at the minimum acceptable level of 30 mL/hour. In 
addition, subjects who required formal resuscitation with 
lactated Ringer's solution for longer than 36 hours 
postburn were considered resuscitation failures. Sub-
jects in the control population who developed resuscita-
tion failure were dropped from the control protocol; at 
that time, they underwent a course of plasma exchange as 
a therapeutic maneuver. Any monitoring devices in place 
were continued throughout the 48 hour period. Inclusion 
of such subjects in the control group was continued but 
the development of failure to resuscitate placed them in 
a subgroup for statistical analysis. 
statistical Anal is Technique 
Data collection was performed using two 24-hour flow 
sheets for each subject. The data were collected on each 
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subject immediately after the conclusion of the 48 hour 
study period. Data were analyzed using the Statistical 
Package for the Social Sciences Program. A UNIVAC 1100 
computer processed the statistical programs. Statistics 
utilized to describe the sample were descriptive in 
nature and included means, standard errors, ranges and 
frequencies (%). In addition, t-test analysis was 
performed on 321 selected variables measured to determine 
whether or not significant differences occurred between 
the control and treatment groups. Because of the ex-
ploratory nature of the work and the small number of sub-
jects studied, statistical significance is defined at 
the .05 level. The technique of survival statistics was 




An experimental study designed to evaluate the effect 
of plasma exchange on subjects in burn shock was con-
ducted. Subjects assigned to the control group received 
standard burn shock resuscitation while the experimental 
group (PLA/EX) received standard burn shock resuscitation 
plus plasma exchange. Built into the design of the study 
was a means to periodically evaluate the data. This 
chapter presents the statistical analyses of data from an 
initial sample of 14 subjects. These data are presented 
in tabular form beginning with the description of the 
sample. Following the descriptive data, the two specific 
questions concerning the physiological response to treat-
ment by group will be presented. 
The Sample 
Student's t-tests of 2-tail probability were conduc-
ted to identify statistical differences between the two 
groups on all variables. The list of all measured var-
iables is presented in Appendix I. 
Fourteen patients with 40% TBSA burn or greater were 
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admitted to the study between July 1982, and December 
1983. Ten (71%) male and four (29%) females were included 
(Table 2). The cause of injury in all cases was flame. 
Five subjects (36%) had documented associated inhalation 
injury. The mean age was 37.6 years (range: 20-52). The 
mean percent total body surface area (TBSA) burn was 51.2 
(range: 40-83) with a mean full-thickness component of 
28.4% TBSA (range: 0-46). The mean body weight was 77 
kg (range: 56-93) with a mean body surface area (BSA) of 
2 
1.9 m (range 1.55 to 2.25). Thirteen of the 14 subjects 
(93%) survived burn shock. Eleven subjects (79%) sur-
vived the burn injury. 
The two subject groups were compared for differences 
on these variables (Table 3). The control group consis-
ted of six males (86%) and one female (14%); the PLA/EX 
group consisted of four males (57%) and three females 
(43%). The incidence of inhalation injury was documented 
in one control subject (14%) and four PLA/EX subjects 
(57%). The mean age of control subjects was 36.7 years 
(range: 23-52). The PLA/EX group had a mean age of 38.4 
years (range: 20-49). The control group had a mean burn 
size of 48.9% TBSA (range: 40-83). 
PLA/EX subjects had a mean burn size of 53.6% TBSA 
(range: 44-71). There was no statistical difference 
(p>.05) between the groups on these variables. A statis-
tical1y significant difference was found on the variable 
Table 2 - Descriptive Characteristics of Sample (n=14 )* 
Variable No.(%) Mean SE Range 
Sex 
Male 10 (71) 
Female 4 ( 29) 
Cause of Injury 
Flame 14 (100) 
Inhalation Injury 5 (36) 
Age, Years 37.6 2.98 20-52 
% TBSA Burn 51.2 3.47 40-83 
% Full-Thickness 
TBSA Burn 28.4 3.41 0-46 
Weight, kg 77.0 3.07 56-93 
2 
BSA m 1.9 0.05 1.55-2.25 
Survival of Burn 
Shock 13 (93) 
Survival of Burn 
Injury 11 ( 79) 
*Represents number of cases (No.), frequencies (%), mean, 
standard error (SE), and range. 
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Table 3 - Descriptive Characteristics of Groups* 





Control ~ 6 (86) 
PLA/EX 4 (57) 
Female 
Control 1 ( 14 ) 
PLA/EX 3 (43) 
Inhalation 
Injury 
Control 1 ( 14) 
PLA/EX 4 (57) .111 
Age, Years 
Control 7 36.7 4.86 23-52 
PLA/EX 7 38.4 3.81 20-49 .787 
% TBSA Burn 
Control 7 48.9 6.00 40-83 




Control 7 18.3 3.35 0-25 
PLA/EX 7 38.4 2.33 27-46 .000 
Weight, kg 
Control 7 79.0 3.63 66-93 
PLA/EX 7 74.9 5.12 56-75 .522 
2 
BSA, m 
Control 7 1.95 0.07 1.70-2.25 
PLA/EX 7 1.89 0.08 1.55-2.20 .555 
*Represents number of cases (No.), frequenciess (%), mean, 
standard error (SE), range, and t-test level of signifi-
cance. 
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of percent full-thickness TBSA burn with controls having 
a mean of 18.3% TBSA full-thickness involvement (range: 
0-25) compared to 38.4% (range: 27-46) for PLA/EX sub-
jects (p<.Ol). The mean body weight for controls was 
79.0 kg (range: 66-93) compared to a mean of 74.9 kg 
(range: 56-75) in the PLA/EX group. Body surface area 
2 
(BSA) was a mean of 1.95 m for control (range: 1.70-
2 
2.25) and 1.89 m for PLA/EX subjects (range: 1.55-
2.20). No statistical difference between groups was 
present in either of these variables (p>.05). 
Resuscitation Requirements 
The first proposed question in this study was as 
follows: 
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Does plasma exchange performed during burn shock al-
ter the predicted resuscitation fluid requirements a 
burn nurse may expect to administer to a patient in 
burn shock? 
The Student's t-test was used to analyze the resusci-
tation data. The mean and standard error are reported in 
this situation where the precision of the sample mean as 
an estimate of the population mean was intended. The con-
trol had intravenous (IV) fluid started by a mean of 1.29 
hours postburn (range: 1 to 2 hours). All PLA/EX sub-
jects had IVs infusing by one hour postburn (Table 4). 
The postburn hour (PBH) of arrival in the burn center was 
4.43 for the control (range: 1-7) and 3.43 for the PLA/EX 
group (range: 2-5). During the first 24 hours postburn, 
Table 4. Resuscitation Requirements First 24 Hours Postburn 
Control Group (n=7) PLA/EX Group (n=7) 
Variable Mean SE Range Mean SE Range 
PBH IV Started 1.29 .18 1-2 1.00 .00 1.00 
PBH Arrival in 
Burn Center 4.43 .81 1-7 3.43 .53 2-5 
Fluids to Resusci-
tate, 1st 24 hrs 
mL/kg/hr 3.23 .51 1.83-5.15 3.37 .47 1.90-4.99 
Fluids to Resusci-
tate to seal 
mL/kg/hr 3.30 .59 1.49-4.68 2.91 .49 1.32-5.67 
Fluids to Resusci-
tate, 1st 8 hrs 
mL/kg/hr 1.35 .22 0.50-2.24 1.88 .26 0.65-2.83 
Fluids to Resusci-
tate, 2nd 8 hrs, 
mL/kg/hr 1.12 .28 0.15-2.22 0.82 .24 0.09-1.60 
Fluids to Resusci-
tate, 3rd 8 hrs, 
mL/kg/kr 0.66 .15 0.24-1.34 0.73 .21 0.19-1.77 
BH to Resucita-
tion 27.9 3.14 14-37 22.30* 4.03 9-35 
odium Infused to 
Resuscitation, 
mEq/kg/%TBSA burn 0.61 .09 0.31-0.95 0.67* .13 0.31-1.10 
rine Output to 

















the control group received a mean of 3.23 mL/kg/hr of re-
suscitation fluid (range: 1.83-5.15). The PLA/EX group 
received a mean of 3.37 mL/kg/hr during the first 24 hours 
postburn (range: 1.90-4.99). The mean amount of IV fluid 
to resuscitate subjects until the time when clinical cri-
teria for sealing was met was a mean of 3.30 mL/kg/hr for 
the control (range: 1.49-4.68) and 2.91 mL/kg/hr for the 
PLA/EX group (range: 1.32-5.67). Fluids to resuscitate 
during the first eight PBH period were 1.35 mL/kg/hr for 
the control (range: 0.50-2.24) and 1.88 mL/kg/hr for the 
PLA/EX group (range: 0.65-2.83). Fluids to resuscitate 
during the second eight PBH period were 1.12 mL/kg/hr for 
the control (range: 0.15-2.22) and 0.82 mL/kg/hr for the 
PLA/EX group (range: 0.09-1.60). Fluids to resuscitate 
during the third eight PBH period were 0.66 mL/kg/hr for 
the control (range: 0.24-1.34) and 0.73 mL/kg/hr for the 
PLA/EX group (range: 0.19-1.77). The time to resuscita-
tion for the control was 27.9 hours postburn (range: 14-
37) and 22.3 hours postburn for the PLA/EX group (range: 
9-35). One PLA/EX subject died at PBH 36 without meeting 
the clinical criteria for sealing. The amount of sodium 
infused for resuscitation of the control was a mean of 
0.61 mEq/kg/% TBSA burn (range: 0.31-0.95). The PLA/EX 
group received a mean of 0.67 mEq/kg/% TBSA burn (range: 
0.31-1.10). Urine output to resuscitation was a mean of 
62 mL per hour for the control (range: 38-96) and 105 mL 
per hour for the PLA/EX group (range: 77-142). This 
variable was significantly different (p<.OI). 
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In comparing the control and PLA/EX groups, no dif-
ference was found in any of the variables associated with 
resuscitation requirements (p>.05). Comparison of the 
control to a group designated experimental survivors was 
then conducted. Survival in the group was dependent 
upon clinical criteria of a normal response to burn in-
jury. All control subjects responded as expected to burn 
shock resuscitation and none were deemed resuscitation 
failures. In the experimental PLA/EX group, three sub-
jects (43%) failed to survive in the group. One patient 
died at 36 hours and two patients failed to resuscitate 
and had repeat plasma exchange procedures within 48 hours 
of the burn. Failure to survive in the group was not 
statistically Significant (p>.05) between the groups. A 
subgroup of experimental subjects was identified and 
designated as experimental survivors (EXP-SUR). Compari-
son of the control to EXP-SUR group is reported in Table 
5. Differences between the four EXP-SUR subjects and the 
seven control subjects failed to achieve statistical sig-
nificance (p>.05) on resuscitation variables due to low 
t-test power. 
The second 24 hours of burn shock was also studied 
regarding fluid requirements (Table 6). The predicted 
maintenance was determined using previously described 
Table 5. Resuscitation Requirements First 24 Hours Postburn 
Control Group (n=7) EXP-SUR Group* (n=4) 
Mean SE Range Variable Mean SE Range 
PBH IV Started 1.29 
PBH Arrival in 
Burn Center 4.43 
Fluids to Resusci-
tate 1st 24 hrs 
mL/kg/hr 3.23 
Fluids to Resusci-
tate to seal, mL/ 
kg/hr 3.30 
Fluids to Resusci-
tate 1st 8 hrs 
mL/kg/hr 1.35 
Fluids to Resusci-
tate 2nd 8 hrs 
mL/kg/hr 1.12 
Fluids to Resusci-




Sodium Infused to 
Resuscitation 
mEq/kg/%TBSA burn 0.61 




.18 1-2 1.00 .00 
.81 1-7 3.25 .75 
.51 1.83-5.15 3.46 .75 
.59 1.49-4.68 2.S0 .71 
.22 0.50-2.24 2.06 .29 
.28 0.15-2.22 0.S6 .42 
.15 0.24-1.34 0.48 .14 
3.14 14-37 17.30 3.71 
.09 0.31-0.95 0.60 .1S 
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methods (Appendix J). The controls were predicted to 
need 267 mL/hr of IV fluid (range: 217-360) and the 
PLA/EX group 267 mL/hr (range: 206-318). The actual 
volume delivered during the second 24 hours postburn was 
a mean of 337 mL/hr in the control (range: 226-481) com-
pared with a mean of 392 mL/hr for the PLA/EX group 
(range: 239-608). The volume delivered from the time 
the subject met the clinical criteria of sealing until 
PBH 48 was a mean of 376 mL/hr for the control (range: 
276-549) and 380 mL/hr (range: 235-601) for the PLA/EX 
group. Hourly urine output for the second 24 hour period 
was a mean of 106 mL/hr (range: 48-258) for the control 
and 84 mL/hr (range: 63-112) for the PLA/EX group. 
Urine output from the time of sealing until PBH 48 was a 
mean of 131 mL/hr for the control (range: 57-213) and 86 
mL/hr (range: 68-126) for the PLA/EX group. The amount 
of FFP to be delivered to each subject was determined 
using previously described formulas (Appendix J). The 
mean amount for the control was 858 mL (range: 660-
1,264) and the PLA/EX group mean was 911 mL (range: 750-
1,120). The actual mean amount of FFP delivered was 866 
mL for the control (range: 
the PLA/EX group (range: 
660-1,250) and 1,004 mL for 
800-1,680). The postburn hour 
of administration was a mean of 31.6 hours for the con-
trol (range: 23-40) and 21.5 hours for the PLA/EX group 
(range: 14-29). There was no statistical difference be-
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tween groups (p>.05) on any of the variables presented in 
Table 6 except for PBH of administration of FFP. There 
the control and PLA/EX groups differed significantly 
(p<.Ol). The EXP-SUR group was again compared with the 
control and the data are presented in Table 7. No sta-
tistically significant differences between the groups 
were found (p>.05) except for the variable PBH of FFP ad-
ministration where statistical significance was again 
reached (p<.05). 
Data regarding the plasma exchange (PLA/EX) procedure 
are presented in Table 8. The mean time of actually star-
ting the procedure was PBH 10 (range: 7-19). The mean 
time of ending PLA/EX was PBH 15 (range: 10-23). Using 
previously described formulas (Appendix J) the calculated 
amount of volume to be exchanged was determined to be a 
mean of 8,278 mL (range: 6,720-9,555). The actual ex-
changed volume was a mean of 7,539 mL (range: 6,000-
9,300). The urine volume during PLA/EX was a mean of 229 
mL/hr (range: 119-507). 
The past medical history of the subjects was reviewed 
to determine any concomitant injury or illness. One sub-
ject (7%) had preexisting cardiac problems (Table 9). 
Two subjects (14%) had gastrointestinal disease; three 
subjects (21%) had a history of alcohol abuse; one subject 
(7%) had a history of drug abuse; and two subjects (14%) 
had intercurrent trauma. Seven of the nine problems 
Table 7. Resuscitation Requirements - Second 24 Hours Postburn 
Control Group (n=7) EXP-SUR Group (n=4) 
Variable Mean SE Range Mean SE Range Probability 
Predicted Mainte-
nance Rate mL/hr 267 17.72 217-360 264.0 28.85 206-318 .933 
Volume Delivered 
2nd 24 hrs, 
mL/hr 337 38.27 226-481 369.0 86.04 239-608 .749 
Volume Resus. 
time-PBH 48 
mL/hr 376 45.04 276-549 359.0 83.78 235-601 .869 
Urine Output 
2nd 24 hrs 
mL/hr 106 30.25 48-258 72.0 5.25 63-84 .311 
Urine output 
Resus. Time-
PBH 48, mL/hr 131 26.16 57-213 71.0 2.02 68-77 .064 
Predicted FFP 
Need, mL 858 76.81 660-1264 887.0 50.34 750-992 .757 
FFP Administered 866 79.77 660-1250 1063.0 207.02 800-1680 .424 





Table 8 - Plasma Exchange Procedure 
PLA/EX Group (n=7) 
Variable Mean SE Range 
PBH Started 10 1.55 7-19 
PBH Ended 15 1.54 10-23 
Calculated Volume 
to be exchanged, 
mL 8278 389.22 6720-9555 
Exchanged Volume, 
mL 7539 487.33 6000-9300 
IUrine Volume 
During PLA/EX, 
mL/hr 229 53.14 119-507 
III 
Table 9 - Past Medical History 
~ariable No. (%) Group Assignment 
Control PLA/EX 
No. ( % ) No. ( % ) 
Ristory of 
Cardiac Disease 1 ( 7 ) 0 ( 0 ) 1 ( 14 ) 
Pulmonary Disease 0 ( 0 ) 0 ( 0 ) 0 ( 0 ) 
Diabetes 0 ( 0 ) a ( 0 ) a ( 0 ) 
Renal Disease 0 ( 0 ) a ( 0 ) a ( a ) 
Gastrointestinal 
Disease 2 ( 14 ) 1 ( 14 ) 1 (14) 
Neurologic 
Disease 0 ( 0 ) 0 ( 0 ) 0 ( 0 ) 
Hepatic Disease a ( 0 ) a ( a ) a ( 0 ) 
Alcohol Abuse 3 ( 21 ) 1 (14) 2 ( 28 ) 
Drug Abuse 1 ( 7 ) 0 ( a ) 1 ( 14 ) 
Intercurrent Trauma 2 ( 14 ) 0 ( 0 ) 2 (28) 
occurred in PLA/EX subjects. 
Physiologic Variables and the Effect 
of Plasma Exchange--
The second specific research question was: 
Does plasma exchange performed during burn shock 
alter measurable physiologic variables? 
The total number of measured variables collected on each 
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subject entered into the research protocol was 945 (Appen-
dix H). For the purpose of this study, 321 selected rep-
resentative variables are reported. This includes the 
previously described data plus the measured physiologic 
variables for PBH 8, 16, 24, and 48. The data were sta-
tistically analyzed for difference between groups using 
the Student's t-test. Because this was a clinical study 
occurring in the rcu area, one limitation of the study was 
that there were times when variables were not measured or 
were not recorded. The number (N) and percent (%) of 
total cases is therefore included in the tables to repre-
sent the actual sample size of each reported variable. 
The representative times were chosen to identify early 
burn shock effect (PBH 8), postplasma exchange effect 
(PBH 16), end of burn shock phase (PBH 24), and restora-
tion of cardiovascular integrity (PBH 48). 
Hematology 
The white blood cell (WBC) count was initially ele-
vated in both the control and the PLA/EX group (Table 10). 
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Table 10 - Hematology 
Variable PBH Group Mean SE Range No. (%) 
WBC, K/uL 8 Control 19.9 3.39 8.0-32.0 6 (86) 
16 14.1 3.37 2.7-24.3 6 (86) 
24 10.6 2.86 3.9-22.0 6 (86) 
48 4.6 1.38 1.8-10.8 6 (86) 
8 PLA/EX 27.8 6.61 17.6-53.5 5 (72) 
16 21.9 3.65 10.8-34.7 7(100) 
24 18.1 3.67 3.6-27.9 7(100) 
48 7.7 1.53 4.5-11.8 4 ( 57) 
RBC, m/uL 8 Control 5.5 0.23 4.82-6.03 5 ( 72) 
16 5.6 0.31 4.60-6.75 6 (86) 
24 5.8 0.34 4.80-6.95 6 (86) 
48 4.4 0.19 3.70-4.90 6 (86) 
8 PLA/EX 5.0 0.62 3.20-6.80 5 ( 72) 
16 5.4 0.32 3.80-6.00 7(100) 
24 5.0 0.37 3.60-6.20 7(100) 
48 4.8 0.18 4.30-5.20 4 (57) 
HGB, g/dL 8 Control 17.6 1.04 14.6-21.3 6 (86) 
16 17.2 0.88 13.9-19.6 6 (86) 
24 17.4* 0.77 14.5-19.3 6 (86) 
48 13.1 0.51 12.0-15.0 6 (86) 
8 PLA/EX 14.7 1.63 9.5-18.9 5 (72) 
16 15.7 0.96 11.4-18.2 7(100) 
24 14.4 0.72 11.4-16.4 7(100) 
48 13.9 0.46 13.0-15.0 4 ( 57) 
HCT, % 8 Control 52 2.85 42.8-60.9 6 (86) 
16 51 2.71 40.9-58.3 6 ( 86) 
24 52* 2.54 42.9-59.1 6 ( 86) 
48 40 1.45 35.8-45.5 6 (86) 
8 PLA/EX 43 5.05 27.8-55.2 5 (72) 
16 47 2.88 33.2-51.7 7(100) 
24 44 2.92 32.8-55.5 7(100) 
48 43 1.66 38.7-46.7 4 (57) 
Platelets, 8 Control 295* 28.29 234-403 6 (86) 
K/uL 16 223* 13.67 175-266 6 (86) 
24 193* 13.44 138-224 6 ( 86) 
48 94* 8.59 67-126 6 (86) 
8 PLA/EX 215 18.14 162-274 5 (72) 
16 133 11.76 81-169 7(100) 
24 101 21.74 45-215 7(100) 
48 55 12.10 19-71 4 (57) 
* p<.05 
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Both groups had WBC counts within normal limits (3.6 to 
9.0 k/pL) (Appendix G) by PBH 48. At no measured time was 
a statistically significant difference identified (p>.05) 
on this variable. The red blood cell (RBC) count was 
within normal limits (WNL ~ 4.71 to 5.77 m/pL) for both 
groups throughout the measured times with the exception of 
the PBH 48 control which was 4.4 m/uL. No statistical 
difference was found between the groups on this variable 
(p>.05). Hemoglobin (HGB) was significantly different 
(p<.05) between the groups at PBH 24 when the control 
mean was 17.4 g/dL and the PLA/EX mean was 14.4 g/dL. 
Both groups maintained HGB levels at values within normal 
limits (WNL) (14.5-17.1 g/dL) until PBH 48 when both de-
creased. Hematocrit (Hct) was significantly different 
between the groups at PBH 24 when the control mean value 
was 52% and the PLA/EX mean was 44%. Other PBH means 
were not different between the groups (p>.05). Both 
groups ranged within normal limits (43 to 52%) except for 
PBH 48 in the control when the mean was 40%. Platelets 
were significantly lower (p<.05) in the PLA/EX group at 
all times, including preplasma exchange. The mean pre-
exchange value was 295 k/~L for the control and 215 kl;uL 
for the PLA/EX group. The control dropped below the 
lower limits of normal (140 to 440K!;uL) by PBH 48 and the 
PLA/EX dropped below by PBH 16. 
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Chemistries 
Serum sodium mean levels remained WNL (137 to 146 
mEq/L) for both groups at all reported times until PBH 48 
when both groups dropped below the lower normal limit 
(Table 11). A statistically different (p<.Ol) sodium 
level occurred between the group means at PBH 16. The 
control mean sodium was 137 mEq/L compared to a mean 145 
mEq/L in the PLA/EX group. No statistically significant 
difference (p>.05) existed in other PBH means. 
Potassium means were significantly different between 
the groups at PBH 16 and PBH 24. The control potassium 
mean was 4.3 mEq/L at both times compared to the PLA/EX 
mean of 3.2 mEq/L at PBH 16 and 3.1 mEq/L at PBH 24 
(p<.05). The control group mean potassium remained WNL 
(3.8-5.3 mEq/L) until PBH 48, at which time the mean of 
3.5 mEq/L was below the normal lower limit. The PLA/EX 
group mean potassium was below the lower normal limits at 
all measured PBH intervals. 
Chloride mean values were slightly elevated from nor-
mal (100-109 mEq/L) at PBH 8, 16, and 24. PLA/EX values 
remained WNL at all measures. A statistically significant 
difference (p<.05) was found between the groups at PBH 24 
when the mean control was III mEq/L compared to 106 mEq/L 
for the PLA/EX group. No difference was found at other 
measures (p>.05). 
Total carbon dioxide (CO) was lower in the control 
2 
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Table 11 - Chemistries 1 
Variable PBH Group Mean SE Range No. ( % ) 
Sodium, 8 Control 137 0.99 134-141 6 ( 86) 
mEq/L 16 137* 2.56 134-140 6 ( 86) 
24 137 2.75 133-150 6 (86) 
48 133 1.63 127-139 6 (86) 
8 PLA/EX 143 2.50 137-151 6 (86) 
16 145 2.03 139-152 7(100) 
24 143 1.92 136-149 7(100) 
48 131 3.75 121-144 5 (72) 
Potassium, 8 Control 4.1 0.20 3.6-4.8 6 (86) 
mEq/L 16 4.3* 0.23 3.7-5.2 6 (86) 
24 4.3* 0.22 3.5-4.8 6 (86) 
48 3.5 0.18 3.0-4.0 6 (86) 
8 PLA/EX 3.5 0.42 2.5-5.0 6 (86) 
16 3.2 0.13 2.7-3.8 7(100) 
24 3.1 0.17 2.5-3.6 7(100) 
48 3.7 0.28 3.0-4.0 5 (72) 
Chloride, 8 Control III 1.20 106-114 6 (86) 
mEq/L 16 III 1.36 105-115 6 (86) 
24 111* 0.58 109-113 6 (86) 
48 105 1.34 100-109 6 (86) 
8 PLA/EX 108 2.60 102-118 6 (86) 
16 108 1.11 104-113 7(100) 
24 106 1.13 104-112 7(100) 
48 101 1.18 97-104 5 (72) 
Total CO2, 8 Control 17 1.95 10-23 6 (86) 
mEq/L 16 19 1.17 17-23 6 ( 86) 
24 18* 0.70 16-21 6 (86) 
48 24 1.75 19-28 6 (86) 
8 PLA/EX 22 2.71 10-29 6 ( 86) 
16 24 2.29 17-33 7(100) 
24 26 1.44 20-32 7(100) 
48 24 2.16 20-31 5 (72) 
BUN, mg/dL 8 Control 13 1.33 10-19 6 (86) 
16 11 0.96 7-14 6 (86) 
24 15 1.88 8-20 6 (86) 
48 10 1.26 6-14 6 ( 86) 
8 PLA/EX 13 1.34 7-17 6 ( 86) 
16 14 1.82 7-22 7(100) 
24 13 1.09 9-17 7(100) 
48 9 1.97 3-14 5 (72) 
1c p<.05 
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at all PBH means but a statistically significant differ-
ence (p<.05) occurred only at PBH 24 when the control mean 
was 18 mEq compared to 26 mEq/L for the PLA/EX group mean. 
Normal CO levels (21-27 mEq/L) were not reached by the 
2 
control until PBH 48 whereas the PLA/EX means remained WNL 
at all PBH intervals. 
Blood urea nitrogen (BUN) levels remained WNL (6-20 
mg/dL) for both groups at all measured intervals. There 
was no statistical difference between the control and 
PLA/EX group BUN measures at any reported PBH. 
Serum glucose means remained above normal limits (84-
119 mg/dL) at all PBH intervals in both groups (Table 12). 
A statistically significant difference (p<.05) between the 
group means existed at PBH 48 when the control mean glu-
cose level was 172 mg/dL compared to 206 mg/dL for the 
PLA/EX group mean. No difference was found (p>.05) at 
other PBH measures. 
Serum creatinine levels remained WNL (0.9 to 1.4 
mg/dL) for both groups at all PBH measures. No difference 
was found between the control and PLA/EX group mean at any 
measured PBH on this variable (p>.05). 
Uric acid means were not significantly different be-
tween the control and PLA/EX group at any PBH. The mean 
levels remained WNL (4.6-8.5 mg/dL) for both groups until 
PBH 48 when the control mean decreased to 3.9 mg/dL and 
the PLA/EX mean to 3.7 mg/dL. 
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Table 12 - Chemistries 2 
Variable PBH Group Mean SE Range No.(%) 
Glucose, 8 Control 141 17.29 91-211 6 (86) 
mg/dL 16 157 10.44 126-194 6 (86) 
24 173 12.80 135-214 6 (86) 
48 172* 11.15 141-222 6 (86) 
8 PLA/EX 171 20.90 97-223 6 (86) 
16 205 24.56 115-300 7(100) 
24 164 16.25 87-208 7(100) 
48 206 9.37 189-230 5 (72) 
Creatinine, 8 Control 1.1 0.08 0.9-1.4 5 (72) 
mg/dL 16 1.1 0.08 0.9-1.4 6 ( 86) 
24 1.3 0.17 0.9~1.9 6 (86) 
48 1.1 0.09 0.9-1.5 6 (86) 
8 PLA/EX 1.1 0.12 0.7-1.4 6 (86) 
16 1.3 0.19 0.8-2.2 7(100) 
24 1.3 0.12 0.9-1.7 7(100) 
48 0.9 0.10 0.7-1.2 4 (57) 
Uric Acid, 8 Control 6.2 0.44 5.1-7.3 5 (72) 
mg/dL 16 5.2 0.47 4.3-7.1 6 (86) 
24 5.1 0.51 3.7-6.6 5 (72) 
48 3.9 0.28 3.2-5.0 6 (86) 
8 PLA/EX 5.6 1.17 3.4-7.4 3 (43) 
16 6.3 0.84 3.4-9.7 7(100) 
24 5.6 0.73 3.2-8.3 7(100) 
48 3.7 1.02 2.2-6.7 4 (57) 
Calcium, 8 Control 7.9* 0.19 7.4-8.4 5 (72) 
mg/dL 16 7.3 0.19 6.7-7.9 6 ( 86) 
24 7.2 0.37 6.4-8.6 5 (72) 
48 6.8 0.21 6.3-7.6 6 (86) 
8 PLA/EX 6.8 0.16 6.4-7.1 4 (57) 
16 6.8 0.27 6.1-8.2 7(100) 
24 6.6 0.25 6.0-7.9 7(100) 
48 6.0 0.43 5.3-7.2 4 (57) 
Phosphate, 8 Control 3.5 0.43 2.4-4.8 5 (72) 
mg/dL 16 3.6 0.30 2.6-4.7 6 (86) 
24 2.9 0.21 2.2-3.3 5 ( 72) 
48 1.7 0.19 1.2-2.5 6 (86) 
8 PLA/EX 3.1 0.48 2.1-4.4 4 (57) 
16 2.9 0.61 1.0-6.0 7(100) 
24 2.7 0.32 1.3-3.9 7(100) 
48 1.4 0.28 0.9-2.2 4 (57) 
* p<.05 
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Total calcium means were significantly different 
(p<.05) at PBH 8 when the control mean was 7.9 mg/dL 
compared to 6.8 mg/dL for the PLA/EX group. No other PBH 
mean was significantly different on the variable (p>.05). 
Both the control and PLA/EX means were below the lower 
limit of normal (8.6-10.7 mg/dL) at all PBH intervals. 
Serum phosphate mean levels were not significantly 
different (p>.05) between the groups at any PBH interval. 
Mean values remained WNL (2.4 to 4.1 mg/dL) until PBH 48 
when both groups decreased below the lower limit of nor-
mal. 
Total bilirubin and direct bilirubin were both found 
not to be significantly different (p>.05) between group 
means at any PBH interval (Table 13). Total bilirubin 
means remained WNL (0.3 to 1.9 mg/dL) as did direct bili-
rubin means (0.0 to 0.3 mg/dL). 
Total protein mean values were not significantly 
different (p>.05) between the control and PLA/EX group at 
any PBH interval. The means in both groups at all PBH 
intervals remained below the lower limits of normal (6.4-
8.1 g/dL). 
Albumin mean values were not significantly different 
(p>.05) between the groups. At no time did the mean 
levels reach the lower limits of normal for albumin (4.0 
to 5.1 g/dL). 
Cholesterol mean levels were initially WNL (128-288 
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Table 13 - Chemistries 3 
Variable PBH Group Mean SE Range No. (%) 
jI'ota1 Bi1i- 8 Control 1.0 0.16 0.6-1.5 5 (72) 
rubin, 16 0.9 0.14 0.5-1.3 6 (86) 
mg/dL 24 0.9 0.26 0.4-1.7 5 (72) 
48 1.2 0.57 0.5-4.0 6 (86) 
8 PLA/EX 0.9 0.19 0.5-1.4 4 (57) 
16 1.5 0.32 0.3-2.4 7(100) 
24 1.3 0.30 0.5-2.7 7(100) 
48 1.2 0.36 0.5-2.1 4 (57) 
Direct Bi1 8 Control 0.18 0.04 0.1-0.3 5 (72) 
rubin, 16 0.12 0.02 0.1-0.2 6 (86) 
mg/dL 24 0.12 0.02 0.1-0.2 5 (72) 
48 0.13 0.02 0.1-0.2 6 (86) 
8 PLA/EX 0.15 0.03 0.1-0.2 4 ( 57) 
16 0.19 0.06 0.0-0.5 7(100) 
24 0.16 0.02 0.1-0.2 7(100) 
48 0.13 0.05 0.0-0.2 4 (57) 
Total Protein 8 Control 4.5 0.36 3.4-5.0 4 (57) 
g/dL 16 3.3 0.36 2.0-5.0 6 (86) 
24 3.4 0.60 1.8-5.5 5 (72) 
48 3.5 0.20 3.0-4.0 6 (86) 
8 PLA/EX 3.5 0.44 2.6-4.7 4 (57) 
16 3.8 0.37 2.0-5.0 7(100) 
24 3.8 0.30 2.8-5.2 7(100) 
48 3.4 0.28 3.0-4.0 4 (57) 
~lbumin, 8 Control 2.7 0.28 1.9-3.2 5 (72) 
g/dL 16 2.0 0.24 1.0-3.0 6 (86) 
24 2.0 0.38 1.1-3.4 5 (72) 
48 1.9 0.17 1.0-2.0 6 (86) 
8 PLA/EX 2.0 0.36 1.3-3.0 4 (57) 
16 2.4 0.22 1.0-3.0 7(100) 
24 2.3 0.20 1.6-3.1 7(100) 
48 2.0 0.13 2.0-2.0 4 (57) 
Cholesterol, 8 Control 157 24.25 97-242 5 (72) 
mg/dL 16 119 12.40 84-158 6 (86) 
24 III 17.06 66-147 5 (72) 
48 98 8.16 74-122 6 (86) 
8 PLA/EX 145 23.14 95-200 4 (57) 
16 117 5.48 90-133 7(100) 
24 114 6.26 89-144 7(100) 
48 114 12.74 90-149 4 (57) 
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mg/dL) for both groups at PBH 8 but then decreased below 
the lower limit of normal at all subsequent PBH intervals. 
No significant difference was found on this variable be-
tween the control and PLA/EX group (p>.05). 
GGTP mean values remained WNL (5-85 rU/L) at all PBH 
intervals (Table 14). A statistically significant dif-
ference (p<.Ol) was found between the groups at PBH 24 
when the control mean was 32 rU/L and the PLA/EX was 11 
rU/L. No significant difference was found at other PBH 
intervals (p>.05). 
Alkaline phosphatase (ALK PHOS) means were not 
significantly different between groups 1p>.05) at any PBH 
interval. The mean values were WNL (40-139 rU/L) at all 
PBH intervals in both the control and PLA/EX group. 
LDH mean values were above normal (138-328 rU/L) in 
the control group at PBH 8 and 24. The PLA/EX group had 
elevated LDH means at all PHB intervals. No statistically 
different mean values were found between the control and 
PLA/EX group (p>.05). 
SGOT mean values were above normal (11-43 rU/L) at 
PBH 8 and 24 in the control and all PBH in the PLA/EX 
group. No statistical difference was found between the 
control and PLA/EX group on this variable. 
SGPT mean values remained WNL (11-85 rU/L) in both 
groups at all PBH intervals. No significant difference 
was found between the groups. 
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Table 14 - Chemistries 4 
Variable PBH Group Mean SE Range No. ( % ) 
~GTP, lUlL 8 Control 30 11.00 11-73 5 (72) 
16 23 5.35 8-47 6 (86) 
24 32* 2.56 25-41 5 (72) 
48 13 2.02 9-20 5 ( 72) 
8 PLA/EX 17 4.33 9-29 4 (57) 
16 12 2.03 6-22 7(100) 
24 11 1.26 8-18 7(100) 
48 9 1.20 7-11 3 (43) 
~LK PHOS, 8 Control 74 3.61 60-80 5 (72) 
lulL 16 53 7.61 26-81 6 (86) 
24 54 13.84 27-105 5 (72) 
48 57 4.21 44-68 5 (72) 
8 PLA/EX 57 19.44 15-108 4 (57) 
16 54 3.91 39-69 7(100) 
24 55 3.21 42-67 7(100) 
48 71 12.49 53-95 3 (43) 
LDH, lulL 8 Control 404 52.13 311-519 4 (57) 
16 305 38.97 202-440 6 ( 86) 
24 343 59.65 230-558 5 (72) 
48 289 38.31 225-407 5 (72) 
8 PLA/EX 513 170.32 213-999 4 (57) 
16 365 36.58 188-498 7(100) 
24 414 78.26 273-852 7(100) 
48 482 112.64 296-685 3 ( 43) 
SGOT, lulL 8 Control 46 9.76 30-82 5 (72) 
16 30 3.66 18-44 6 (86) 
24 46 13.72 25-99 5 (72) 
48 25 2.46 21-33 5 (72) 
8 PLA/EX 51 16.62 25-99 4 (57) 
16 45 8.29 17-79 7(100) 
24 52 12.69 17-99 7(100) 
48 57 22.05 24-99 3 (43) 
SGPT, lulL 8 Control 35 8.88 20-69 5 (72) 
16 30 4.88 15-45 6 (86) 
24 38 9.87 5-67 5 (72) 
48 20 3.62 12-33 5 (72) 
8 PLA/EX 32 5.92 22-46 4 (57) 
16 29 3.22 12-39 7(100) 
24 31 6.71 12-56 7(100) 
48 42 25.70 11-93 3 ( 43) 
* p<.Ol 
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Lactic acid mean values were above normal (0.5-2.2 
mEq/L) at all PBH intervals in both the control and PLA/EX 
groups (Table 15). No statistically significant difference 
was found between the groups at any PBH interval. 
Coagulation Studies 
Prothrombin time (PT), patient, was prolonged above 
normal values (10.0-14.4 seconds) in the control group at 
PBH 24 and in the PLA/EX group at PBH 8 (Table 16). Mean 
values for PT, control, were WNL (32 to 48 seconds) at 
all PBH intervals for both control and PLA/EX group. No 
statistical difference was found between the two groups 
on this variable (p>.05). Partial thromboplastin time 
(PTT) patient and PTT control remained WNL in both the 
control group and the PLA/EX group at all PBH intervals. 
No significant difference between the means of control 
and PLA/EX group was found (p>.05). Fibrinogen mean 
values remained WNL (150-350 mg/dL) in both the control 
and PLA/EX groups until PBH 48 when the control mean was 
elevated to 552 mg/dL and PLA/EX mean was 490 mg/dL. No 
statistically significant difference was found at any PBH 
between group means (p>.05). 
Pulmonary Variables 
The fraction of inspired oxygen (FiO ) mean was above 
2 
that of room air (21%) at all PBH intervals in both groups 
(Table 17). There was a statistically significant dif-
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Table 15 - Chemistries 5 
Variable PBH Group Mean SE Range No. ( % ) 
Lactic Acid, 8 Control 3.4 0.87 1.6-6.6 5 ( 72) 
mEq/L 16 3.5 0.90 1.0-7.0 6 (86) 
24 4.1 0.85 1.9-7.0 6 (86) 
48 2.6 0.24 2.0-4.0 6 (86) 
8 PLA/EX 4.5 1.22 2.1-8.5 5 (72) 
16 7.5 1.70 3.0-16.0 7(100) 
24 5.2 0.77 2.7-7.6 7(100) 
48 2.8 0.35 2.0-4.0 5 ( 72) 
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Table 16 - Coagulation Studies 
Variable PBH Group Mean SE Range No. ( % ) 
PT patient, 8 Control 12.6 0.47 11.0-13.7 5 (72) 
Sec. 16 14.0 0.39 13.2-15.7 6 (86) 
24 15.1 0.49 13.2-16.4 6 (86) 
48 13.0 0.47 11.0-15.0 6 ( 86) 
8 PLA/EX 14.9 1.82 12.1-22.0 5 (72) 
16 14.0 0.58 12.4-16.3 7(100) 
24 14.1 0.58 12.2-16.2 7(100) 
48 13.3 0.34 12.0-14.0 5 (72) 
~T Control, 8 Control 12.2 0.18 11.8-12.7 5 (72) 
Sec. 16 12.3 0.13 11.9-12.7 6 (86) 
24 12.4 0.11 12.1-12.8 6 ( 86) 
48 12.3 0.15 12.0-13.0 6 (86) 
8 PLA/EX 13.2 0.87 11.9-16.6 5 ( 72) 
16 12.7 0.39 11.7-14.8 7(100) 
24 12.7 0.41 11.7-14.9 7(100) 
48 12.5 0.26 12.0-13.0 5 (72) 
PTT Patient, 8 Control 32 0.68 30-33 5 (72) 
Sec. 16 36 1.77 32-42 6 (86) 
24 38 2.75 27-45 6 (86) 
48 34 1.51 30-41 6 (86) 
8 PLA/EX 40 3.91 30-54 5 (72) 
16 42 2.35 35-53 7(100) 
24 42 2.62 33-52 7(100) 
48 36 2.28 30-42 5 (72) 
PTT Control, 8 Control 38 1.14 34-40 5 ( 72) 
Sec. 16 38 1.02 34-41 6 (86) 
24 39 0.43 37-40 6 (86) 
48 38 0.49 37-40 6 (86) 
8 PLA/EX 41 2.58 37-51 5 (72) 
16 39 0.72 37-42 7(100) 
24 40 1.06 36-45 7(100) 
48 39 0.45 38-40 5 (72) 
Fibrinogen, 8 Control 235 21.96 196-297 4 ( 57) 
mg/dL 16 249 15.86 197-290 6 ( 86) 
24 319 34.00 255-380 4 (57) 
48 552 39.39 450-694 6 (86/ 
8 PLA/EX 202 42.94 60-320 5 (72' 
16 209 14.41 153-274 7(100' 
24 256 23.36 170-265 7(100/ 
48 490 65.33 322-626 4 (57~ 
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Table 17 - Pulmonary 
Variable PBH Group Mean SE Range No. ( % ) 
Fi02, % 8 Control 32 3.26 21-40 7(100) 
16 34* 2.71 21-40 7(100) 
24 32 3.26 21-40 7(100) 
48 28 .. 3.56 21-40 7(100) 
8 PLA/EX 49 8.62 35-10 7(100) 
16 43 2.64 35-50 7(100) 
24 41 5.52 21-70 7(100) 
48 31 5.02 21-50 6 (86) 
Resp. Rate/ 8 Control 17 2.01 9-24 7(100) 
min. 16 21 1.44 15-24 7(100) 
24 19 2.05 11-25 7(100) 
48 21 1.99 14-29 7(100) 
8 PLA/EX 18 2.39 9-24 7(100) 
16 18 1.54 14-26 7(100) 
24 18 2.27 9-25 7(100) 
48 16 1.24 12-20 6 (86) 
~ore Body 8 Control 37.4 0.32 36.5-39.0 7(100) 
Temp. , 16 38.0 0.20 37.0-39.0 7(100) 
Degrees C 24 38.1 0.30 37.5-39.8 7(100) 
48 37.7 0.25 37.0-39.0 7(100) 
8 PLA/EX 36.8 0.25 36.0-37.4 6 (86) 
16 38.3 0.31 37.0-39.0 7(100) 
24 37.7 0.35 35.9-38.6 7(100) 
48 37.7 0.16 37.0-38.0 6 (86) 
% Intubated 8 Control 4 (57) 
16 4 (57) 
24 4 (57) 
48 3 (43) 
8 PLA/EX 4 (57) 
16 5 (72) 
24 4 (57) 
48 4 (57) 
*p<.05 
127 
ference between the groups at PBH 16 when the control mean 
FiO was 34% compared to 43% for the PLA/EX group. No 
2 
other PBH intervals were statistically different (p>.OS). 
The mean respiratory rate for both groups at all PBH in-
tervals was WNL and not statistically different between 
groups (p>.OS). 
Core body temperature was recorded as a pulmonary 
variable because it is one of the known variables neces-
sary to calculate blood gas analyses. All mean core body 
temperature values were WNL (36.0-39.0 degrees C) at all 
PBH intervals and no statistically significant difference 
was found between the control and PLA/EX group (p>.OS). 
The percent of patients intubated at each PBH interval is 
presented in Table 17. A total of nine patients (64%) 
required intubation. There is no significant difference 
between the groups on this variable (p>.OS). 
Arterial blood gas determinations were made on all 
patients (Table 18). Oxygen saturation (02 SAT) mean was 
WNL (>93%) in both the control and PLA/EX group at all 
PBH intervals. No significant difference was found on 
this variable between groups at any PBH interval (p>.OS). 
Appendix C presents normal values for blood gas analysis. 
PO mean value was above normal (68-78 mmHg) at all 
2 
PBH intervals in the control group and until PBH 48 in the 
PLA/EX group. No statistical difference was found between 
group mean PO levels (p>.OS). 
2 
PCO mean value was at or 
2 
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Table 18 - Arterial Blood Gas Analysis 
Variable PBH Group Mean SE Range No. (%) 
02 SAT, % 8 Control 96 1.96 86-98 6 (86) 
16 97 0.52 95-99 7(100) 
24 97 0.89 93-99 6 (86) 
48 96 0.68 94-99 7(100) 
8 PLA/EX 93 3.06 76-99 7(100) 
16 97 0.46 95-99 7(100) 
24 96 0.48 94-97 7(100) 
48 95 0.48 94-97 6 (86) 
P02, mmHg 8 Control 150 22.85 62-213 6 (86) 
16 118 12.06 73-159 7(100) 
24 116 12.65 70-159 6 (86) 
48 88 8.14 71-132 7(100) 
8 PLA/EX 132 23.01 39-205 7(100) 
16 137 32.94 83-330 7(100) 
24 86 6.32 71-118 7(100) 
48 77 4.13 63-92 6 (86) 
IPC02, mmHg 8 Control 29 4.66 12-40 6 (86) 
16 29 2.30 20-36 7(100) 
24 28* 1.47 23-33 6 (86) 
48 31 1.25 28-35 7(100) 
8 PLA/EX 34 2.08 27-42 7(100) 
16 32 2.72 20-41 7(100) 
24 33 1.50 26-38 7(100) 
48 33 2.55 27-42 6 (86) 
pH 8 Control 7.44 0.06 7.28-7.69 6 (86) 
16 7.43 0.03 7.30-7.50 7(100) 
24 7.44 0.02 7.39-7.52 6 (86) 
48 7.47 0.02 7.40-7.50 7(100) 
8 PLA/EX 7.39 0.04 7.23-7.58 7(100) 
16 7.48 0.04 7.40-7.70 7(100) 
24 7.49 0.02 7.43-7.55 7(100) 
48 7.47 0.02 7.40-7.50 6 (86) 
Bicarbonate, 8 Control 18.0 1.47 13.7-23.3 6 (86) 
mEq/L 16 19.1* 1.00 16.0-23.0 7(100) 
24 18.7* 0.85 15.1-20.7 6 (86) 
48 22.9 1.12 20.0-28.0 7(100) 
8 PLA/EX 20.9 1.82 14.3-26.3 7(100) 
16 23.8 1.69 17.0-31.0 7(100) 
24 25.0 1.51 17.9-30.2 7(100) 
48 24.1 2.37 19.0-32.0 6 (86) 
* p<.05 
129 
below normal values (31-41 mmHg) at all measured PBH in-
tervals. PLA/EX group mean values were WNL at all PBH in-
tervals. A statistically significant difference was found 
between PCO levels at PBH 24 when control mean was 28 
2 
mmHg compared to a mean PLA/EX value of 33 mmHg (p<.05). 
other PBH means did not significantly differ between 
groups (p>.05). Arterial pH values were different from 
normal (7.35 to 7.45) in the control at PBH 48 and in the 
PLA/EX group at PBH 16, 24, and 48. These differences 
were not significant between the control and PLA/EX group 
at any PBH interval. 
Bicarbonate levels were below normal (22.0-26.0 
mEq/L) in the control at PBH 8, 16, and 24 and in the 
PLA/EX group at PBH 8. A statistically significant dif-
ference was found between groups at two PBH intervals, PBH 
16 and 24 (p<.05). At PBH 16, the control mean bicarbo-
nate value was 19.1 mEq/L compared to 23.8 mEq/L in the 
PLA/EX group. At PBH 24, the control mean was 18.7 mEq/L 
compared to 25.0 mEq/L for the PLA/EX group. Other PBH 
interval means were not significantly different (p>.05). 
Mixed venous blood gas determinations were analyzed 
for each patient (Table 19). Oxygen saturation (0 SAT) 
2 
was maintained WNL (60-85%) in both groups at all PBH in-
tervals (Appendix C presents normal values for mixed ve-
nous blood analysis). A significant difference (p<.05) 
was found between the groups at PBH 16 when the control 
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Table 19 - Mixed Venous Blood Gas Analysis 
Variable PBH Group Mean SE Range No. (%) 
02 SAT, % 8 Control 75 2.80 70-83 4 (57) 
16 75* 1.53 70-81 7(100) 
24 69 2.16 64-76 6 (86) 
48 74 2.02 68-80 6 (86) 
8 PLA/EX 69 8.20 36-97 6 (86) 
16 65 3.74 50-77 7(100) 
24 69 3.08 59-79 7(100) 
48 67 4.21 53-76 5 (72) 
~02, mmHg 8 Control 37 3.19 31-43 4 (57) 
16 39 2.40 28-46 7(100) 
24 37 2.45 30-46 6 (86) 
48 37 1.97 32-46 6 (86) 
8 PLA/EX 45 11.37 19-99 6 (86) 
16 33 2.67 25-46 7(100) 
24 34 2.03 27-39 7(100) 
48 33 3.91 23-44 5 (72) 
lPC02, mmHg 8 Control 27* 4.26 20-39 4 (57) 
16 33 2.36 25-42 7(100) 
24 32* 0.68 30-34 6 (86) 
48 35 1.28 31-38 6 (86) 
8 PLA/EX 42 2.38 32-47 6 (86) 
16 40 3.47 21-49 7(100) 
24 37 2.15 29-45 7(100) 
48 36 2.52 31-45 5 (72) 
pH 8 Control 7.46 0.04 7.39-7.56 4 (57) 
16 7.41 0.03 7.30-7.50 7(100) 
24 7.41 0.02 7.36-7.49 6 (86) 
48 7.44 0.02 7.40-7.50 6 (86) 
8 PLA/EX 7.36 0.04 7.20-7.43 6 (86) 
16 7.44 0.04 7.30-7.60 7(100) 
24 7.46 0.01 7.39-7.49 7(100) 
48 7.43 0.02 7.40-7.50 5 (72) 
Bicarbonate, 8 Control 18.8 1.64 15.5-23.3 4 (57) 
mEq/L 16 20.2* 0.87 18.0-24.0 7(100) 
24 20.3* 1.13 17.8-25.1 6 (86) 
48 23.8 1.08 21.0-28.0 6 (86) 
8 PLA/EX 23.5 1.97 17.1-28.9 6 (86) 
16 26.2 1.61 22.0-32.0 7(100) 
24 26.4 1.22 21.5-31.1 7(100) 
48 24.0 2.49 18.0-33.0 5 (72) 
"* p<.05 
mean 0 SAT was 75% compared with a PLA/EX group mean of 
2 
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65%. Other PBH interval means were not significantly dif-
ferent (p>.05). PO mean values were also kept either at 
2 
or above normal values at all PBH intervals. There was no 
significant difference between the groups at any PBH mean 
value (p>.05). 
peo mean control values were below the normal range 
2 
(38-50 mmHg) at all PBH intervals. The PLA/EX values were 
WNL at PBH 8 and 16 and below normal at PBH 24 and 48. 
There was a significant difference between the groups at 
PBH 8 and 24 (p<.05). At PBH 8, the control peo was 27 
2 
mmHg compared to 42 mmHg for the PLA/EX group. At PBH 24, 
the control peo was 32 mmHg compared to 37 mmHg for the 
2 
PLA/EX group. No significant difference was found between 
the groups at other PBH intervals for this variable 
(p>.05). 
Serum pH mean levels were different from normals 
(7.32-7.42) at PBH 8 and 48 in the control and at PBH 16, 
24, and 48 in the PLA/EX group_ No significant difference 
was found between the group means at any PBH interval 
(p>.05). Bicarbonate levels were less than the lower 
limit of normal (22-29 mEq/L) in the mean control values 
at PBH 8, 16, and 24. All PLA/EX group means were WNL at 
all PBH intervals. A significant difference was found 
between the groups at PBH 16 and 24. The control mean 
bicarbonate at PBH 16 was 20.2 mEq/L compared to 26.2 
132 
mEq/L for the PLA/EX group. At PBH 24, the control mean 
was 20.3 mEq/L compared to the PLA/EX group value of 26.4 
mEq/L. Other PBH intervals did not show a significant 
difference. 
Base Excess 
Arterial blood gas (ABG) base excess mean values 
were WNL (-3 to 3) at all PBH control intervals except 
PBH 8 when the mean value was -3.5 (Table 20). The 
PLA/EX group means remained WNL at all PBH intervals. 
There was a significant difference between the groups 
(p<.05) at PBH 16 and 24. At PBH 16, the control mean 
base excess was -3.0 compared to 1.9 for the PLA/EX 
group. At PBH 24, the control mean base excess was -3.1 
comapred to 3.0 for the PLA/EX group. No significant 
difference was found between the groups at other PBH in-
tervals measured (p>.05). The mixed venous blood base 
excess mean was WNL at all PBH intervals for the control 
and all except PBH 24 for the PLA/EX group. There was a 
significant difference between groups on PBH 16 and 24 
(p<.05). The control PBH 16 mean was -2.8 compared to 
2.7 for the PLA/EX group. The control PBH 24 mean value 
was -2.6 compared to 3.5 for the PLA/EX group. There was 
no significant difference between the groups at other PBH 
intervals. 
Cardiopulmonary Profile 
The physiological variables either measured by or 
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Table 20 - Base Excess 
Variable PBH Group Mean SE Range No. ( % ) 
~BG Base 8 Control -3.5 1.29 -7.6 to 0.5 6 (86) 
Excess 16 -3.0* 1.08 -7.0 to 0 7(100) 
24 -3.1* 1.10 -6.8 to 0.9 6 (86) 
48 0.6 1.43 -3.0 to 6.0 6 (86) 
8 PLA/EX -2.7 2.44 -12.2 to 6.3 7(100) 
16 1.9 1.80 -6.0 to 8.0 7(100) 
24 3.0 1.56 -3.7 to 8.2 7(100) 
48 1.8 2.26 -5.0 to 9.0 6 (86) 
MVBG Base 8 Control -2.3 1.14 -5.0 to-O. 14 (57) 
Excess 16 -2.8* 1.07 -6.0 to 1.0 7(100) 
24 -2.6* 1.42 -5.9 to 3.S 6 (86) 
48 0.6 1.25 -3.0 to 5.0 6 (86) 
8 PLA/EX -l.S 2.38 -10.9 to 4.6 6 (86) 
16 2.7 1.68 -4.0 to 8.0 7(100) 
24 3.S 1.07 -0.4 to 7.3 7(100) 
48 0.8 2.40 -S.O to 9.0 S (72) 
*p<.OS 
134 
calculated from the Swan-Ganz catheter monitor system are 
referred to as a cardiopulmonary profile. The normal pa-
rameters are presented in Appendix C. 
The pulmonary artery (PA) mean pressure was WNL (9-18 
mmHg) at all PBH intervals for both control and PLA/EX 
groups (Table 21). There was no significant difference 
between the groups on any PBH mean value (p>.05). The 
pulmonary artery wedge pressure (PAWP) was WNL (6-15 
mmHg) at all PBH intervals for the control and all except 
PBH 8 for the PLA/EX group when the mean value was 5 
mmHg. There was no statistical difference between the 
control and PLA/EX group on any PBH mean value for PAWP 
(p>.05). 
Cardiac output was WNL (3.5-6.5 L/min) for the con-
trol from PBH 8 through 24 but was above normal at 6.9 
L/min by PBH 48. The PLA/EX group remained WNL at all PBH 
intervals. There was no statistical difference between 
the control and PLA/EX group on this variable (p>.05). 
Cardiac index as an indicator of cardiac output 
2 
per m BSA likewise showed no statistical difference 
2 
(p>.05). Stroke work index was WNL (41-51 mL/beat/m BSA) 
for both groups at all PBH intervals. No statistical dif-
ference was found between the PBH mean values for this va-
riable (p>.05). 
Systemic vascular resistance index (SVRI) was above 
2 5 
normal values (1970-2390 Dynes/second/m BSA/cm) at PBH 8 
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Table 21 - Cardiopulmonary Profile 
Variable PBH Group Mean SE Range No. (%) 
PA mean 8 Control 11 2.59 5-19 5 ( 72) 
mmHg 16 14 1.86 7-21 7(100) 
24 15 1.46 10-19 6 (86) 
48 17 2.91 6-28 6 (86) 
8 PLA/EX 17 2.44 10-25 5 (72) 
16 13 2.26 5-20 7(100) 
24 17 2.92 10-27 7(100) 
48 16 3.86 7-26 5 (72) 
PAWP, mmHg 8 Control 7 1.00 4-10 5 (72) 
16 7 1.55 3-13 6 (86) 
24 8 1.34 5-11 5 (72) 
48 10 2.26 1-16 6 (86) 
8 PLA/EX 5 1.32 3-8 4 (57) 
16 7 1.76 1-15 7(100) 
24 8 2.31 0-18 7(100) 
48 8 3.39 2-20 5 (72) 
~ardiac Out- 8 Control 5.4 0.66 3.4-7.2 5 (72) 
put, L/Min 16 6.5 1.01 3.7-11.7 7(100) 
24 4.9 0.52 2.9-6.6 6 (86) 
48 6.9 1.02 4.4-9.8 6 (86) 
8 PLA/EX 4.7 0.87 1.3-7.4 6 (86) 
16 5.4 0.63 3.5-8.3 7(100) 
24 5.8 0.45 4.5-7.8 7(100) 
48 5.6 0.41 4.3-6.8 5 (72) 
~ardiac Index, 8 Control 2.7 0.45 1.8-3.2 3 (43) 
L/Min/ 16 3.2 1.03 1.5-7.0 5 (72) 
m2 BSA 24 2.4 0.30 1.6-3.1 5 (72) 
48 3.5 0.67 2.0-5.0 4 (57) 
8 PLA/EX 2.6 0.52 0.6-4.3 6 (86) 
16 3.0 0.43 2.0-5.0 7(100) 
24 3.2 0.35 2.0-4.3 7(100) 
48 3.1 0.33 3.0-4.0 5 (72) 
~troke Work 8 Control 23.8 7.05 16.7-30.8 2 ( 28) 
Index, mL/ 16 36.0 14.46 19.0-65.0 3 (43) 
beat/ 24 24.6 7.38 14.3-38.9 3 (43) 
m2 BSA 48 29.4 5.77 19.0-44.0 4 ( 57) 
8 PLA/EX 24.9 6.62 8.1-39.9 4 (57) 
16 23.6 4.59 11.0-36.0 5 (72) 
24 24.6 4.99 15.3-38.5 4 (57) 
48 24.8 1.88 21.0-32.0 5 (72) 
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for both control and PLA/EX and then returned to WNL for 
the remaining PBH intervals (Table 22). There was no sta-
tistical significance between the groups on this variable 
(p>.05). Pulmonary vascular resistance index (PVRI) was 
2 5 
below normal values (225-315 Dynes/second/m BSA/cm ) in 
the control at PBH 8, 16, and 48 and in the PLA/EX group 
at PBH 16 and 48. No statistical difference in PVRI was 
found at any PBH interval. Systemic blood pressure (BP) 
mean was WNL (70-105 mmHg) at all PBH interval means in 
both groups. Systemic BP diastolic was also WNL (60-90 
mmHg) in both groups at all PBH intervals. There were no 
significant differences between the group means on the va-
riables of mean BP or diastolic BP (p>.05). 
Heart rate was above normal values (80-120 beats/min) 
at PBH 8 in the control and at all intervals in the PLA/EX 
group. The difference was not significant at any PBH 
interval between groups (p>.05). 
Arterial-venous oxygen difference (A-VO DIFF) was 
2 
above normal values (4.6-5.4 mL 0 /100 mL) at PBH 8 and 24 
2 
and below normal at PBH 16 and 48 in the control (Table 
23). The PLA/EX group was above normal at PBH 8, 16, and 
24 and WNL at PBH 48. There was not a significant dif-
ference between the mean PBH interval values (p>.05). 
Oxygen consumption was above the normal of 240 mL/min 
in both groups at all PBH intervals. The difference be-
tween the control and PLA/EX group on the mean 0 con-
2 
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Table 22 - Cardiopulmonary Profile 2 
Variable PBH Group Mean SE . Range No. ( % ) 
Systemic 8 Control 2967 1166.00 1801-4133 2 (28) 
Vascular 16 1919 399.36 903-3287 5 (72) 
Resistance 24 2051 219.91 1432-2667 5 (72) 
Index, 48 2032 536.69 916-3103 4 (57) 
Dynes/sec/ 8 PLA/EX 3865 2052.84 1142-9953 4 (57) 
m2 BSA/ 16 2360 282.75 1498-3116 6 (86) 
emS 24 2166 250.81 1336-2832 5 (72) 
48 2462 186.03 1865-2886 5 (72) 
Pulmonary 8 Control 174 44.50 129-218 2 (28) 
Vascular 16 158 30.57 37-198 5 (72) 
Resistance 24 248 104.98 108-666 5 (72) 
Index, 48 149 30.83 104-208 3 (43) 
Dynes/sec/ 8 PLA/EX 373 205.92 92-985 4 (57) 
m2 BSA/ 16 189 37.25 35-277 6 (86) 
emS 24 246 99.63 71-531 4 (57) 
48 192 85.33 65-519 5 (72) 
~ystemic BP, 8 Control 100 0.00 100 1 ( 14) 
mean, mmHg 16 87 12.01 72-111 3 ( 43) 
24 71 5.49 62-81 3 (43) 
48 80 6.38 62-91 5 (72) 
8 PLA/EX 84 12.01 69-108 3 (43) 
16 86 4.65 75-100 5 (72) 
24 84 5.51 75-94 3 (43) 
48 96 3.93 91-104 3 (43) 
Systemic BP 8 Control 68 3.17 52-76 7(100) 
Diastolic, 16 68 5.82 51-92 7(100) 
mmHg 24 67 5.22 47-88 7(100) 
48 63 5.18 45-80 7(100) 
8 PLA/EX 66 7.08 41-89 6 (86) 
16 71 3.50 58-83 7(100) 
24 70 3.51 58-82 7(100) 
48 76 3.37 62-87 6 ( 86) 
Heart Rate, 8 Control 105 8.90 78-140 7(100) 
Beats/Min. 16 114 9.90 81-147 7(100) 
24 126 8.09 89-151 7(100) 
48 121 5.04 106-142 7(100) 
8 PLA/EX 121 9.69 80-160 7(100) 
16 133 8.93 104-164 7(100) 
24 128 5.80 111-153 7(100) 
48 125 4.64 108-140 6 (86) 
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Table 23 - Cardiopulmonary Profile 3 
Variable PBH Group Mean SE Range No. ( % ) 
A-V 02 8 Control 6.4 2.35 4.0-8.7 2 (28) 
Diff, 16 4.1 0.68 3.0-5.0 3 ( 43) 
mL02/ 24 5.7 0.88 3.9-6.6 3 ( 43) 
100mL 48 3.8 0.33 3.0-5.0 4 (57) 
8 PLA/EX 5.7 0.63 4.0-7.0 4 (57) 
16 6.1 0.76 4.0-9.0 6 (86) 
24 7.2 0.75 5.2-8.8 4 (57) 
48 5.2 0.65 3.0-7.0 5 (72) 
02 Consump- 8 Control 256 40.00 216-296 2 (28) 
tion, mL/min 16 303 70.50 162-374 3 ( 43) 
24 309 65.04 222-436 3 (43) 
48 277 73.31 132-451 4 (57) 
8 PLA/EX 279 71.02 73-376 4 (57) 
16 317 83.69 155-727 6 (86) 
24 427 59.15 333-596 4 (57) 
48 280 18.52 224-324 5 ( 72) 
02 Available 8 Control 537 80.00 457-617 2 (28) 
mL02/min/ 16 735 147.22 490-999 3 (43) 
m2 BSA 24 551 66.56 431-661 3 ( 43) 
48 589 121.46 379-822 4 (57) 
8 PLA/EX 488 120.17 140-653 4 (57) 
16 530 62.63 390-814 6 (86) 
24 585 92.27 468-860 4 (57) 
48 489 23.20 416-550 5 (72) 
02 Ex- 8 Control 27 7.20 20.0-34.4 2 (28) 
tracted, % 16 20 2.51 17.0-25.0 3 (43) 
24 27 3.10 20.8-31.1 3 (43) 
48 23 1.77 19.0-28.0 4 (57) 
8 PLA/EX 31 2.76 24.4-36.9 4 (57) 
16 31 4.25 17.0-49.0 6 (86) 
24 38 0.80 36.3-39.9 4 ( 57) 
48 27 6.96 2.0-44.0 5 (72) 
A-a 02 8 Control 33 13.87 9-65 4 (57) 
Diff, mL02/ 16 48* 10.84 10-75 5 (72) 
100 mL 24 43 10.60 15-72 5 ( 72) 
48 39 15.38 3-99 7(100) 
8 PLA/EX 144 86.83 33-490 5 (72) 
16 113 19.09 34-157 6 (86) 
24 112 34.18 2-291 7(100) 
48 65 25.51 7-160 6 (86) 
* p<.05 
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Table 24 - Cardiopulmonary Profile 4 
Variable PBH Group Mean SE Range No. (%) 
Shunt 8 Control 14 2.50 11-16 2 (28) 
(QS/QT) , % 16 22 2.80 16-30 5 (72) 
24 26 6.74 9-47 5 (72) 
48 26 2.72 18-30 4 (57) 
8 PLA/EX 22 4.66 11-33 4 (57) 
16 22 3.17 9-33 6 (86) 
24 31 7.49 19-53 4 (57) 
48 28 3.85 18-35 4 (57) 
CVP, mmHg 8 Control 8 1.14 5-11 5 (72) 
16 9 2.01 3-15 6 (86) 
24 10 1.94 5-15 5 (72) 
48 9 1.86 1-14 6 ( 86) 
8 PLA/EX 8 2.29 2-17 6 (86) 
16 7 2.13 1-15 6 (86) 
24 9 2.03 2-15 7(100) 
48 5 2.32 1-14 5 (72) 
CHAPTER V 
DISCUSSION 
The purpose of this research was to analyze the data 
collect~d on a group of 14 subjects entered into an ex-
perimental design study for the evaluation of the effect 
of plasma exchange during burn shock. The study was de-
signed to allow periodic review for the purpose of deter-
mining the number of cases necessary to achieve statisti-
cal significance in a prospective manner. This study re-
ports the preliminary findings and specifically addresses 
two nursing research questions. 
The Sample 
The sample was found not to be evenly distributed on 
the very important variable of percent TBSA burn full-
thickness injury (p<.Ol). The control had an 18.3% full-
thickness injury (range: 0-25) compared to the PLA/EX 
group's 38.4% full-thickness injury (range: 27-46). 
Thus, the subjects in the PLA/EX group were significantly 
more injured than the control. This made the other study 
parameters more difficult to interpret since an equal 
result between two groups of subjects when one group is 
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much more severely injured does not necessarily carry the 
same implications for both groups. In addition, while not 
achieving statistical significance, the clinical signifi-
cance of having four of the PLA/EX patients (57%) with in-
halation injury compared to one patient (14%) in the con-
trol further unbalances the severity of clinical injury. 
Thus, the first conclusion is that the sample as now dis-
tributed is uneven, with the PLA/EX group being much more 
critically ill- than the control on the basis of two varia-
bles: percent TBSA full-thickness injury and the inci-
dence of inhalation injury. 
Resuscitation Requirements 
There was no statistically significant difference be-
tween the groups in terms of fluid requirements in total 
nor at PBH 8, 16, and 24. However, the argument could be 
made that since the PLA/EX group was more severely in-
jured, the equal requirement means the PLA/EX therapy 
kept the requirements down. The identification of a sub-
group of subjects, EXP-SUR, was made and this data com-
pared to the control. Statistical significance was not 
achieved on the fluid variable but the EXP-SUR group did 
require less total fluid to resuscitate while, at the 
same time maintaining a significantly higher hourly urine 
output (p<.OI). In addition, the EXP-SUR group required 
more fluid than the control in the first eight hours and 
less in the subsequent two eight-hour periods. The power 
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of the t-test indicates the problem is one of small 
sample size combined with wide ranges on the variables 
measured. Thus, the second conclusion: The initial 
trend appears to support the notion that PLA/EX decreases 
fluid requirements during burn shock but significance has 
not been reached due to insufficient sample size. 
Physiologic Variables 
The effect of PLA/EX on measurable physiologic vari-
ables was also analyzed. Again, the power of the t-test 
indicated an insufficient sample in all but a few vari-
ables. The variables which have reached significance with 
the current sample size are astonishingly strong. 
Hematology 
The parameters of WBC, RBC, HGB, and HCT initially 
all showed the hemoconcentration effect of burn shock. 
Platelets were significantly (p<.05) diminished in the 
PLA/EX group thus demonstrating the reported removal of 
platelets as a side-effect of the PLA/EX procedure. Thus, 
the third conclusion: Plasma exchange significantly de-
creases platelet counts. 
Chemistries 
Chemistry values were not significantly different nor 
were there trends toward differences on most variables. 
As expected, no electrolyte imbalances occurred because 
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all subjects were resuscitated with lactated Ringer's so-
lution. The BUN and creatinine levels remained within 
normal limits in both groups, indicating adequate renal 
perfusion. Glucose levels were slightly elevated, an ex-
pected finding secondary to the stress response. Two 
other variables which differed from normals but were ex-
pected in burn subjects were the findings of low albumin 
levels and elevated lactic acid levels. Thus, conclusion 
four: PLA/EX does not appear to alter serum chemistry 
values from those expected in other burn patients. 
Coagulation Studies 
Coagulation studies, which included prothrombin time 
and partial thromboplastin times, and fibrinogen, were 
not different from normal laboratory control values, from 
normal ranges, nor between study subjects. Thus, the 
following conclusion is made: The coagulopathy reported 
to occur in burn patients was not observed in this group 
of study subjects. 
Pulmonary Variables 
The total group of patients (n=14) sustained flame 
injury which resulted in five patients (36%) sustaining 
inhalation injury. A total of nine patients (64%) re-
quired intubation. One patient died at 36 hours postburn 
from an overwhelming inhalation injury. Arterial and 
mixed venous blood gas analysis determinations were ana-
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lyzed for each subject. Except for occasional statis-
tica1ly significant differences in the pCO mean values, 
2 
there was no difference between groups. Again, since the 
samples are uneven for incidence of inhalation injury 
(1/7 for control; 4/7 for PLA/EX group), it can be argued 
that equal results are actually an indicator of the bene-
fits of PLA/EX in minimizing the clinical response to in-
2 
halation injury. The FiO was significantly higher at 
PBH 16 in the PLA/EX group but not at other PBH intervals. 
In addition, the clinical expectation of patients with se-
vere inhalation injury is that they will require excessive 
amounts of resuscitation fluid. This was not the case for 
this group of subjects with inhalation injury. Thus the 
next conclusion: Statistical significance was not 
reached in the fluid requirements of subjects with inha-
lation injury. This appears to be a function of insuf-
ficient sample size. The base excess was significantly 
different (p<.05) at PBH 16 and 24 in both MVBG and ABG 
determinations with the PLA/EX being in a balance correc-
ted toward 0 while the control was in a much more severe 
negative base excess. Thus the following conclusion: 
The PLA/EX group was in significantly (p<.05) more normal 
base excess balance at both PBH 16 and 24 than was the 
control group. 
Cardiopulmonary Profile 
There were no statistically significant differences 
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between the control and the PLA/EX group on the measured 
cardiopulmonary profiles. Again, this appears to be a 
function of sample size as indicated by the minimal power 
of the t-test. Since it is clinically and statistically 
known that the PLA/EX group is much more severely injured, 
if both groups have the same cardiac index, the results 
may be implied to be better in the PLA/EX group. Thus, 
the following conclusions: There were no statistically 
significant differences between the control and the 
PLA/EX group on the measured cardiopulmonary profiles. 
This appears to be due to insufficient sample size. 
Conclusions 
1. The sample as now distributed is uneven, with the 
PLA/EX group being much more critically ill than the 
control on the basis of two variables: Percent TBSA full-
thickness injury (p<.Ol) and the incidence of documented 
inhalation injury. 
2. Significance has not been reached on the vari-
able of fluid requirement. This appears to be a function 
of insufficient sample size as reflected by the low power 
of the t-test. 
3. PLA/EX significantly decreases platelet count 
(p<.05). 
4. PLA/EX does not appear to alter serum chemistry 
values from the expected values of subjects with burn 
injury. 
5. The coagulopathy reported to occur in burn 
patients was not observed in this group of subjects. 
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6. Statistical significance was not reached on the 
fluid requirements of subjects with inhalation injury. 
This appears to be a function of insufficient sample 
size. 
7. The PLA/EX group was in significantly (p<.05) 
more normal base excess balance at both PBH 16 and 24. 
8. There is no evidence that the PLA/EX is harmful 
in any way to experimental subjects. 
It is recommended that the study as designed be 
continued until statistical significance is reached or 
rejected. 
APPENDIX A 
LUND AND BROWDER CHART WITH DESCRIPTION OF DEPTH 
OF INJURY 
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Lund and Browder (163) developed a formula for the 
estimation of the total body surface area burn and pub-
lished the results in 1944. Up to that time, "Berkow's 
table" had been used but these investigators reported 
that the data assembled for the table were for metabolic 
work and had been collected primarily to secure a correct 
total body surface area. For this purpose, differences 
in points of division between one region and another were 
unimportant in securing a valid total. In the use to 
which surface area proportions are put with burns, such 
definitions are of great importance. Also, it is of 
great importance to subdivide the surface into as many 
clearly demarcated areas as possible so as to permit the 
easiest possible visual comparison. Body surface area in 
relation to age is another factor which Lund and Browder 
incorporated into the chart. The table and diagrams were 
estimated to be applicable, without serious error, to at 
least 99.5% of all cases of burns. The Lund and Browder 
chart has been used in Burn Centers since its introduc-
tion in 1944. The chart was incorporated into the med-
ical record charting system of this Burn Center upon its 
opening in 1976 (Figure 1). By convention, red is the 
color used to designate full-thickness injury; blue is 
used to designate partial-thickness injury. First degree 
burns are not included in the estimation of total body 
surface area burn. 











R. U. Arm 
L. U. Arm 
R. L. Arm 






























BURN ESTIMATE AND DIAGRAM 
AGE vs. AREA 
1-4 5-9 10-14 15 
yr yr yr. yr. Adult 
17 13 11 9 7 
2 2 2 2 2 
13 13 13 13 13 
13 13 13 13 13 
2'h 2'/2 2'12 2'12 2'12 
2";' 2'/, 2'/2 2'12 2'12 
1 1 1 1 1 
4 4 4 4 4 
4 4 4 4 4 
3 3 3 3 3 
3 3 3 3 3 
2'12 2'/2 2'12 2'12 2'12 
2'12 2'12 2'/2 2'/2 2 '12 
6'/2 8 8'/2 9 9'12 
6'1< 8 8'12 9 9'/2 
5 5'/2 6 6'12 7 
5 5'/2 6 6'12 7 
3'12 3'12 3'12 3'/2 3'12 
3'12 3'12 3'12 3'/2 3'12 
TOTAL 
Donor 
2° 3° Total Areas 
BURN DIAGRAM o Cause of Burn~ ___ ~ __ ~ ________ _ Dateof Burn ~ __ . ____ _ 
Time of Bu rn ____ ._ 
Age __ ~~" ___ _ 
Sex _~ __ , ___ .. _ 
Weight __ 
COLOR CODE 
Red --- 3° 
Blue- 2° 
LUND AND BROWDER CHART 
UHM(' I'!,;' 1\ 4,71 
Figure 1. Burn estimate and diagram. 
Reprinted with permission of 
U of U Medical Center. 
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Depth of Burn Injury 
Burn injury involves the destruction of the integu-
mentary system. The skin is divided into three layers 
(Figure 2). The epidermis, or nonvascular outer layer of 
the skin is about the thickness of a sheet of paper. It 
is composed of epithelial cells that provide a protective 
barrier to the skin, hold in fluids and electrolytes, 
regulate heat, and keep harmful agents in the external 
environment from injuring or invading the body. The 
dermis, lying below the epidermis, is about 30 to 45 
times thicker than the epidermis. The dermis contains 
connective tissues with blood vessels and highly spec-
ialized structures consisting of hair follicles, nerve 
endings, sweat glands, and sebaceous glands. Under the 
dermis lies the subcutaneous tissue containing major vas-
cular networks, nerves, and lymphatics. The subcutaneous 
tissue acts as a shock absorber and heat insulator for 
the underlying structures: muscles, tendons, bones, in-
ternal organs, etc. 
In the past, burns were defined by degrees: first 
degree, second degree and third degree. The American 
Burn Association currently advocates a more explicit 
physiological definition categorizing the burn according 
to depth: partial- and full-thickness. Table 25 re-







Cross-section of skin indicating burn and 
structures involved. 
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on pressure. Pain 
and mild swelling 
present. No ves-
icles or blisters 
(although after 24 
hours skin may 
blister and peel). 
Caused by super-
ficial sunburn or 
quick heat flash. 
2nd degree (deep) Fluid-filled 
vesicles. Red, 
shiny, wet (if 
vesicles have 
ruptured). Very 
painful due to 
nerve injury. Mild 
to moderate edema. 
Full thickness 
3rd and 4th 
degree 
Caused by flash, 
scald, or flame 
burn. 
Dry, waxy white, 
leathery or hard. 
Thrombosed vessels 
often visible. In-
sensitive to pain 
and pressure. Due 
to nerve destruc-
tion. Can involve 
muscles, tendons and 
bones. 
Caused by flame, 
scald, chemicals, 































BLOOD REQUIREMENTS FOR LAB VALUES 
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Table 26. Blood Requirements for Lab Values to be 
Drawn During the Randomized Trial of 
Plasma Exchange Therapy in Patients 
































































Arterial and Mixed Venous Blood Gas 
The values reported in this study were determined by 
the Pulmonary Laboratory, University of Utah Medical 
Center. All values have been adjusted for the elevation 
above sea level and the barometric pressure at the time 
of analysis. Normal values for this laboratory are pre-
sented in Table 27. 
Hemodynamic Parameters 
Hemodynamic parameters are measured directly using 
instrumentation previously described. The normal values 
for these parameters are presented in Table 28. 
Computed Cardiopulmonary Parameters 
The computation of cardiopulmonary parameters is 
performed within the Cardiopulmonary Profile Program 
developed by Tenet Information Services, Salt Lake 
City, Utah. Normal values are presented in Table 29. 
The Cardiopulmonary Profile Program is designed to op-
timally utilize values from arterial blood gases, mixed 
venous blood gases and other data obtained from a Swan-
Ganz catheter. The values are derived using the fol-
lowing procedures. 
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Table 27. Arterial and Mixed Venous Blood Gas Normal 
Values Breathing Room Air 
Value Arterial Normal Range 
PO , mmHg 
2 
o Saturation, % 
2 
pH 











31 to 41 
-3 to 3 




35 to 40 
60 to 85 
7.32 to 
7.42 
38 to 50 
-3 to 3 
22 to 29 
Table 28. Hemodynamic Parameters 
Value Parameter 
Systemic Blood Pressure 
Mean, mmHg 
Diastolic, mmHg 
Pulmonary Artery Pressure 
Mean, mmHg 
Pulmonary Artery Wedge 
Pressure, mmHg 






















Table 29. Cardiopulmonary Profile Predicted Values 
Profile Predicted Value 
















Stroke Work Index 
QS/QT (Shunt) 
A-a 0 Difference 
2 




550 to 650 mL 0 /min/m BSA 
2 
23 to 27% 
70 to 105 mmHg 
9 to 16 mmHg 
225 to 315 Dynes/second/ 
2 5 
m BSA/cm 
1970 to 2390 Dynes/second/ 
m2 BSA/cm5 
2 
41 to 51 mL/beat/m BSA 
17 to 31% 
< 8 
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Arterial to Venous Oxygen Difference 
Arterial to venous oxygen difference is calculated 
if the following criteria are met: 
1. Arterial PO or arterial oxygen content are 
2 
reported. 





= Art. 0 
2 




Oxygen consumption is calculated if the following 
criteria are met: 
1. No measured value is entered. 
2. Measured cardiac output is entered. 
3. The criteria for A-Va diff. are met. 
2 
va = Cardiac output (meas.) X 1000 X A-VO diff. 
2 2 
Oxygen Availability 
Oxygen availability is calculated if the following 
criteria are met: 
1. Arterial 0 
entered. 
2 
content and/or arterial PO 
2 
2. Cardiac output is entered or calculated. 
3. Patient height and weight are entered. 
are 




Oxygen extraction is calculated if the criteria for 
A-VO differences are met: 
2 
o ext = art. 0 
2 2 
content-VO cont. X 100% 
2 
art. 02 cont. 
Systemic Arterial Pressure Mean (MAP) 
MAP = Systolic Pressure +2 (Diastolic Pressure) 
and 
MAP = Diastolic 
Pressure 
pulmonary Artery Pressure 






Pulmonary artery pressure mean is calculated if the 
following criteria are met: 
1. Systolic pulmonary artery pressure is reported. 
2. Diastolic pulmonary artery pressure is reported. 





Pulmonary vascular resistance index is calculated if 
the following criteria are met: 
1. Systolic arterial blood pressure is reported. 
2. Diastolic arterial blood pressure is reported. 
3. Wedge pressure is reported. 
4. Cardiac output (either measured or calculated) 
is reported. 
5. Patient weight and height are reported. 
PVR = 79.96 (mean PAP - Wedge Pressure) 
Cardiac Index 
Systemic Vascular Resistance 
Index 
Systemic vascular resistance index is calculated if 
the following criteria are met: 
1. Systemic systolic blood pressure is reported. 
2. Systemic diastolic blood pressure is reported. 
3. Central venous pressure is reported. 
4. Cardiac output is reported. 
5. Patient height and weight are reported. 
SVR = 79.96 (mean SAP - Central Ven. Pressure) 
Cardiac Output 
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SAP == Systemic arterial pressure, 
mean SAP (Systolic SAP-Diastolic SAP)+Diastolic SAP 
3 
SVR index == 79.96 (mean SAP-Central Ven. Pressure) 
Cardiac Index 
Cardiac Index 
This is reported if the following criteria are met: 
1. The criteria for QT are met. 
2. Patient height and weight are entered. 
Cardiac index == (Cardiac Ouptut) 
Body Surface Area 
Stroke Volume Index 
This is calculated if the following criteria are 
met: 
1. The criteria for cardiac output are met. 
2. Patient heart rate is entered. 
3. Patient height and weight are entered. 
Stroke index == (Stroke Volume) 
Body Surface Area 




Shunt is calculated if the following criteria are 
1. Criteria for capillary content are met. 




3. Mixed venous PO or mixed venous oxygen content 
2 
are reported: 
QS/QT :::: Pul. Cap. a cont.-Art. a cont. 
2 2 
x 100. 
Pule Cap. a cont.-Ven. a cont. 
2 2 
APPENDIX D 
COMPOSITION OF SOLUTIONS AND FLUIDS 
Table 30. Composition of Lactated Ringer's Solution 
Compared with Extracellular Fluid 
Electrolyte Extracellular* Fluid 
Sodium, mEq/L 135-145 
Potassium, mEq/L 3.2-4.5 
Chloride mEq/L 95-105 







NOTE. *Normal values may vary slightly from one test 
laboratory to another; ** Plus 80-100 mL free 
water per liter; *** Lactate is converted by 
liver into bicarbonate. 
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APPENDIX E 












































































































































































































BODY SURFACE AREA CHART 
171 
Directions: To find body surface of a patient, locate 
the height in inches· (or centimeters) on scale I and the 
weight in pounds (or kilograms) on Scale II and place a 
straight edge (ruler) between these two points which will 







































PATHOLOGY LABORATORY VALUES 
Table 32. Normal Ranges of Laboratory Values 
Laboratory Value Normal Range 
Hematology 
White blood cell 






































































% TBSA burn 










Time postburn IV 
Fluid resuscitation started 
< 1 hour=l 
n hour=n 
Hours postburn of arrival in burn center 
Total fluids to resuscitation expressed as 
cc/kg/% TBSA burn/first 8 hrs postburn 
cc/kg/% TBSA burn/second 8 hrs postburn 
cc/kg/% TBSA burn/third 8 hrs postburn 
Time to resuscitation 
Total sodium infused expressed as 
mEq/kg/% TBSA burn/time to resuscitation 
Weight in kg 
Body surface area 
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Urine output expresed as mean cc/hr/time to resuscitation 
Past medical history 
O=no history of disease 














Survival of burn shock 
O==yes 
l==no 






Plasma exchange group 
Postburn hour started 
Postburn hour stoppped 
Calculated volume: 
males = (7% body weight in kg X 1.5) 
females = (8% X kg X 1.5) 
Urine volume during procedure expressed as cc/hr 
predicted maintenance rate expressed in cc/hr 
Actual volume received in second 24 hours expressed in 
mean cc/hr 
Actual volume received from resuscitation time through 
postburn hour 48 expressed in mean cc/hr 
176 
Urine output expressed in mean cc/hr during 2nd 24 hours 
Urine output expressed in mean cc/hr during resuscitation 
time 
Calculated amount FFP 
Delivered amount FFP 
Postburn hour of administration 
Blood products required 
O=no 
n=amount 
Postburn hour administration started 
Death in first 48 hours 
O=no 
n=postburn hour of death 
Death due to burn=days 
O=no 
n=postburn day of death 
Cause of death 
O=no death 
l=overwhelming inhalation injury 
2=metabolic exhaustion 
3=sepsis 
4=failure to resuscitate 
Failure to survive in group 
O=no failure 





3=failure to resuscitate. 
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The following variables were measured at admission and 
every four hours thereafter (PBH 4,8,12,16,20,24,28,32, 
36,40,44 and 48). 
Blood Analyses 




Red blood cell count 
Prothrombin time-patient 
prothrombin time-control 
Partial thromboplastin time-patient 





Total carbon dioxide 











Lactate dehydrogenase (LDH) 
Serum glutamic-oxaloacetic transaminase (SGOT) 











4=manually ventilated with mask 
5=manually ventilated with intubation 
6=ventilated with Bear 
Tidal volume 
O=spontaneous 








Positive end-expiratory pressure (PEEP) 
Spontaneous respiratory rate 
















Pulmonary artery mean pressure (PA mean) 
Pulmonary artery wedge pressure (PAWP) 
Cardiac output (C.O.) 
Cardiac index (C.l.) 
Stroke work index (SWl) 
Systemic vascular resistance index (SVRI) 
Pulmonary vascular resistance index (PVRI) 
Systemic blood pressure - mean 
Systemic blood pressure-diastolic 
Heart rate 





A-a oxygen difference 








Blood Draws Upon Admission: 
1. ABG, MVBG, CBC with differential, SMA-6, SMA-20, 
Lactic Acid, PT, PTT, Fibrinogen (to lab on regular 
slips). 
Plasma Exchange: 
1. Draw (1) above pre- and postexchange. Send to 
lab with appropriate requisition slips. 
2. Put plasma in fridge in dirty utility room after 
labeling it. 























1. S-G: Record all Swan-Ganz parameters including 
CVP. 
2. C.O.: Do 3 cardiac output measures and record 
average measure. 
3. C.P.: Cardiac parameters. 
ABGs and MVBG and send slip to 
for cardiopulmonary profile. 
4. V. S. : TPR, B. P. 
Postburn Hour 
V. S. , S-G, C.O. , C. P. , labs ( 1) , 
V. S. , C.O. , S-G 
V.S. 
V. S. , S-G. , C. o. , C. P. , lab ( 1 ) 
V.S. 
V. S. , C. o. , S-G 
V.S. 
V.S, S-G, C.O. , C. P. , lab ( 1 ) 
V.S. 
V. S. , C. o. , S-G 
V.S. 
V. S. , C. o. , S-G, C. P. , lab ( 1 ) 
V.S. 
V. S. , C. o. , S-G, 
V.S. 
V. S. , c.o. , S-G, C. P. , lab ( 1 ) 
V.S. 
V. S. , C. o. , S-G 
V.S. 
V. S. , C. o. , S-G, C. P. , lab ( 1 ) 
So S-G and C.O. plus 
computer technician 
( 2) , ( 3 ) 
21. V.S. 
22. V. S. , 
23. V.S. 
24. V. S. , 
25. V. S. , 
26. V.S. 
27. V.S. 
28. V. S. , 
29. V.S. 










40. V. S. , 
41. V.S. 
42. V. S. , 
43. V.S. 




48. V. S. , 
c. 0., S-G 
c.o., S-G, C.P., lab (1) 
START 24 hour urine 
c.o., S-G 
lab (1) 
c. 0., S-G, c. P. 
c.o., S-G, lab (1) 
c.o., S-G, C.P. 
lab (1) 
c.o., S-G 





A. Fluid Balance 
1. Total volume received during resuscitation=mL 
2. Total urine output during resuscitation=mL 
3. Resuscitation fluid received= 
[Total volume received - (urine output+basal fluid 
requirements)]mL 
4. Volume of fluid/kg body weight/% TBSA burn to 
resuscitate patient: 
Total volume 
= mL/kg/% TBSA burn. 
kg X % TBSA burn 
B. Sodium Balance 
1. Total sodium received=mEq/Kg% TBSA burn 
2. mEq of sodium/kg body weight/% burn to 
resuscitate patient: 
Total mEq Sodium 
= mEq Sodium/kg/% TBSA burn. 
kg X % TBSA burn 
C. Basal Fluid Requirements 
1. Body surface area using nomogram (Appendix F) 
2. Basal fluid requirements= 
2 
a. 1500/mL/m BSA = mL per 24 hrs 
2 
b. 1500 mL/m BSA 
= mL per hr. 
24 hrs 
D. Colloid Replacement: 
1. Adult males: 20% (5% X kg) = mL fresh frozen 
plasma (FFP) 
2. Adult females: 20% (8% X kg) = mL FFP. 
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